Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Heart Failure
  Free Subscription

Articles published in
Int J Cardiol
    June 2024
  1. CAI Q, Li Q, Zhong S, Chen M, et al
    Ultrasound-targeted microbubble destruction rapidly improves left ventricular function in rats with ischemic cardiac dysfunction.
    Int J Cardiol. 2024;404:131943.
    >> Share

    May 2024
  2. SPERLONGANO S, Benfari G, Ilardi F, Lisi M, et al
    Role of speckle tracking echocardiography beyond current guidelines in cardiac resynchronization therapy.
    Int J Cardiol. 2024;402:131885.
    >> Share

    April 2024
  3. TERAMOTO K, Nochioka K, Sakata Y, Kato ET, et al
    Growth differentiation factor-1?5 and metabolic features in chronic heart failure: Insights from the SUPPORT Trial -GDF15 across the BMI spectrum.
    Int J Cardiol. 2024 Apr 23:132093. doi: 10.1016/j.ijcard.2024.132093.
    >> Share

  4. CHEW-HARRIS J, Frampton C, Greer C, Appleby S, et al
    Prognostic performance of soluble urokinase plasminogen activator receptor for heart failure or mortality in Western and Asian patients with acute breathlessness.
    Int J Cardiol. 2024 Apr 19:132071. doi: 10.1016/j.ijcard.2024.132071.
    >> Share

  5. PEZZUTO B, Contini M, Berna G, Galotta A, et al
    Dynamic trend of lung fluid movement during exercise in heart failure: From lung imaging to alveolar-capillary membrane function.
    Int J Cardiol. 2024 Apr 19:132041. doi: 10.1016/j.ijcard.2024.132041.
    >> Share

  6. HONG Y, Gao Z, Wei H, Wei Y, et al
    Bi-directional association of body size and composition with heart failure: A Mendelian randomization study.
    Int J Cardiol. 2024 Apr 19:132069. doi: 10.1016/j.ijcard.2024.132069.
    >> Share

  7. JONG CB, Lu TS, Chen JW
    Reply to comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
    Int J Cardiol. 2024 Apr 10:132031. doi: 10.1016/j.ijcard.2024.132031.
    >> Share

  8. ESPERSEN C, Campbell RT, Claggett BL, Lewis EF, et al
    Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure.
    Int J Cardiol. 2024 Apr 8:132036. doi: 10.1016/j.ijcard.2024.132036.
    >> Share

  9. GLINGE C, Rossetti S, Oestergaard LB, Stampe NK, et al
    Familial clustering of unexplained heart failure - A Danish nationwide cohort study.
    Int J Cardiol. 2024 Apr 5:132028. doi: 10.1016/j.ijcard.2024.132028.
    >> Share

  10. NAKAO M, Nagai T, Anzai T
    Iron supplementation is a residual piece of management in Asian patients with heart failure?
    Int J Cardiol. 2024 Apr 4:132014. doi: 10.1016/j.ijcard.2024.132014.
    >> Share

  11. DE MICHIELI L, Stoppa G, Sinigiani G, Previato L, et al
    Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the Veneto Region, Italy.
    Int J Cardiol. 2024;400:131804.
    >> Share

  12. DE SA MARCHI MF, van den Dorpel M, Calomeni P, Chatterjee S, et al
    Comparative analysis of different risk prediction tools after mitral Transcatheter edge-to-edge repair.
    Int J Cardiol. 2024;400:131768.
    >> Share

  13. GARCIA-MOLL X, Lopez L
    Safety of sacubitril/valsartan among older adults. Where real world data meet clinical trials results.
    Int J Cardiol. 2024;400:131706.
    >> Share

    March 2024
  14. CHENG Y, Zhang Q
    Comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
    Int J Cardiol. 2024 Mar 26:131979. doi: 10.1016/j.ijcard.2024.131979.
    >> Share

  15. YAO L, Gong X, Liu Y, Hao K, et al
    The miR-195-3p/BDNF axis is a promising therapeutic for heart failure.
    Int J Cardiol. 2024 Mar 22:131991. doi: 10.1016/j.ijcard.2024.131991.
    >> Share

  16. CARIGI S, Gentile P, Gori M, Tinti D, et al
    Clinical characteristics, treatment, trajectories and outcome of patients with dilated cardiomyopathy in a national heart failure registry.
    Int J Cardiol. 2024 Mar 19:131986. doi: 10.1016/j.ijcard.2024.131986.
    >> Share

  17. KARAKITSOS P, Mylonas KS
    Raw data were not disclosed in 95% of PubMed-indexed heart failure meta-analyses in 2021: A systematic analysis of transparency.
    Int J Cardiol. 2024 Mar 19:131987. doi: 10.1016/j.ijcard.2024.131987.
    >> Share

  18. HUA L, Zhang R, Chen R, Shao W, et al
    A nomogram for predicting the risk of heart failure with preserved ejection fraction.
    Int J Cardiol. 2024 Mar 18:131973. doi: 10.1016/j.ijcard.2024.131973.
    >> Share

  19. LUND-ANDERSEN C, Yafasova A, Hofsten D, Thune JJ, et al
    Association between QRS shortening and mortality after cardiac resynchronization therapy: Results from the DANISH study.
    Int J Cardiol. 2024;399:131700.
    >> Share

  20. CHAO-CHEN L
    Letter to the Editor: "Changes in walking speed 6 months after discharge may be more sensitive to subsequent prognosis than handgrip strength in patients hospitalized for heart failure".
    Int J Cardiol. 2024 Mar 13:131958. doi: 10.1016/j.ijcard.2024.131958.
    >> Share

  21. BACKHAUS SJ, Schulz A, Lange T, Schmidt-Schweda LS, et al
    Prognostic and diagnostic implications of impaired rest and exercise-stress left atrial compliance in heart failure with preserved ejection fraction: Insights from the HFpEF stress trial.
    Int J Cardiol. 2024 Mar 11:131949. doi: 10.1016/j.ijcard.2024.131949.
    >> Share

  22. BARSSOUM K, Abumoawad A, Chowdhury M, Agrawal A, et al
    Perioperative outcomes of hypertrophic cardiomyopathy: An insight from the National Readmission Database.
    Int J Cardiol. 2024;398:131601.
    >> Share

    February 2024
  23. KIKO T, Aoki T
    The relationship between duration of delirium and clinical outcomes in patients with acute heart failure.
    Int J Cardiol. 2024 Feb 23:131902. doi: 10.1016/j.ijcard.2024.131902.
    >> Share

  24. LUO Z, Gong X, Liu Y, Hao K, et al
    Mitochondrial dysfunction due to miR-210/Drd5/ROS axis is a potential mechanism of heart failure.
    Int J Cardiol. 2024 Feb 20:131897. doi: 10.1016/j.ijcard.2024.131897.
    >> Share

  25. GUAZZI M, Crisci G
    Exercise mean PAP to CO relationship: An insightful endpoint for testing therapeutic interventions in heart failure.
    Int J Cardiol. 2024 Feb 20:131899. doi: 10.1016/j.ijcard.2024.131899.
    >> Share

  26. SIM DKL, Mittal S, Zhang J, Hung CL, et al
    Expert recommendations for the management of iron deficiency in patients with heart failure in Asia.
    Int J Cardiol. 2024 Feb 19:131890. doi: 10.1016/j.ijcard.2024.131890.
    >> Share

  27. LERMAN TT, Greenberg N, Fishman B, Goldman A, et al
    The real-world safety of sacubitril / valsartan among older adults (>/=75): A pharmacovigilance study from the FDA data.
    Int J Cardiol. 2024;397:131613.
    >> Share

  28. LV L, Chen Q, Lu J, Zhao Q, et al
    Potential regulatory role of epigenetic modifications in aging-related heart failure.
    Int J Cardiol. 2024 Feb 13:131858. doi: 10.1016/j.ijcard.2024.131858.
    >> Share

  29. ISMAIL TF
    Understanding heart failure and cardiomyopathy in Africa: Insights from cardiovascular magnetic resonance.
    Int J Cardiol. 2024 Feb 12:131847. doi: 10.1016/j.ijcard.2024.131847.
    >> Share

  30. HAGE C, Lund LH
    Inflammation and myeloperoxidase - The next treatment targets in heart failure?
    Int J Cardiol. 2024 Feb 5:131834. doi: 10.1016/j.ijcard.2024.131834.
    >> Share

  31. LI G, Liu X, Long A, Feng J, et al
    An inducible mouse model of heart failure targeted to cardiac Drd5 deficiency detonating mitochondrial oxidative stress.
    Int J Cardiol. 2024;396:131560.
    >> Share

  32. IANNACCONE M, Barbero U, Franchin L, Montabone A, et al
    Comparison of mid-term mortality after surgical, supported or unsupported percutaneous revascularization in patients with severely reduced ejection fraction: A direct and network meta-analysis of adjusted observational studies and randomized-controlle
    Int J Cardiol. 2024;396:131428.
    >> Share

    January 2024
  33. FERREIRA JP, Claggett BL, Liu J, Sharma A, et al
    High-sensitivity C-reactive protein in heart failure with preserved ejection fraction: Findings from TOPCAT.
    Int J Cardiol. 2024 Jan 31:131818. doi: 10.1016/j.ijcard.2024.131818.
    >> Share

  34. XU L, Chen Y, Chen S, Wang G, et al
    Relationship between resting heart rate and long-term outcomes in stabilized patients with myocardial infarction: A prospective community-based cohort study.
    Int J Cardiol. 2024 Jan 24:131811. doi: 10.1016/j.ijcard.2024.131811.
    >> Share

  35. MIGLIORE F, Schiavone M, Pittorru R, Forleo GB, et al
    Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: Data from a multicenter experience.
    Int J Cardiol. 2024 Jan 23:131807. doi: 10.1016/j.ijcard.2024.131807.
    >> Share

  36. YAMAGUCHI N, Hirata Y, Nishio S, Takahashi T, et al
    Pulmonary pressure-flow responses to exercise in heart failure treated with angiotensin receptor neprilysin inhibitor.
    Int J Cardiol. 2024 Jan 20:131789. doi: 10.1016/j.ijcard.2024.131789.
    >> Share

  37. MUSUMECI B, Tini G, Biagini E, Merlo M, et al
    Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.
    Int J Cardiol. 2024 Jan 18:131784. doi: 10.1016/j.ijcard.2024.131784.
    >> Share

  38. KANG DW, Kang SH, Lee K, Nam K, et al
    Comparative efficacy of vericiguat to sacubitril/valsartan for patients with heart failure reduced ejection fraction: Systematic review and network meta-analysis.
    Int J Cardiol. 2024 Jan 17:131786. doi: 10.1016/j.ijcard.2024.131786.
    >> Share

  39. CHERBI M, Bouisset F, Bonnefoy E, Lamblin N, et al
    Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry.
    Int J Cardiol. 2024;395:131578.
    >> Share

  40. MUROKE V, Jalanko M, Haukka J, Anttila V, et al
    Long-term outcome after surgical correction of sinus venosus defect in a nationwide register-based cohort study.
    Int J Cardiol. 2024;395:131433.
    >> Share

  41. HANADA S, Adachi T, Iwatsu K, Kamisaka K, et al
    Changes in walking speed 6?months after discharge may be more sensitive to subsequent prognosis than handgrip strength in patients hospitalized for heart failure.
    Int J Cardiol. 2024 Jan 11:131778. doi: 10.1016/j.ijcard.2024.131778.
    >> Share

  42. QUATTRONE F, Aimo A, Zuccarino S, Morelli MS, et al
    Unmet needs in end-of-life care for heart failure patients.
    Int J Cardiol. 2024 Jan 10:131750. doi: 10.1016/j.ijcard.2024.131750.
    >> Share

  43. AIKAWA Y, Ogata S, Honda S, Nagai T, et al
    Prolonged delirium during hospitalization is associated with worse long-term and short-term outcomes in patients with acute heart failure.
    Int J Cardiol. 2024 Jan 10:131776. doi: 10.1016/j.ijcard.2024.131776.
    >> Share

  44. PASTORE MC, Vannuccini F, Mandoli GE, Lisi M, et al
    Myocardial work and left heart deformation parameters across primary mitral regurgitation severity.
    Int J Cardiol. 2024 Jan 9:131772. doi: 10.1016/j.ijcard.2024.131772.
    >> Share

  45. SRAYA R, Amsalem I, Carasso S, Gilad O, et al
    Mitral valve gradient changes associate with outcomes of patients undergoing transcatheter edge-to-edge repair.
    Int J Cardiol. 2024 Jan 9:131766. doi: 10.1016/j.ijcard.2024.131766.
    >> Share

  46. MIYOSHI T
    A novel genetically engineered mouse model for investigating heart failure mechanisms and therapeutic interventions.
    Int J Cardiol. 2024 Jan 3:131703. doi: 10.1016/j.ijcard.2023.131703.
    >> Share

  47. EGBE AC, Abozied O, Miranda WR, Younis A, et al
    Prognostic role of inferior vena collapsibility index in congenital heart disease: A validation study.
    Int J Cardiol. 2024;394:131399.
    >> Share

    December 2023
  48. SAEED S, Bleie O
    Prognostic validation of first-phase ejection fraction in patients with heart failure: A new piece of evidence.
    Int J Cardiol. 2023 Dec 31:131692. doi: 10.1016/j.ijcard.2023.131692.
    >> Share

  49. TAN Z, Liu Y, Hong K
    The association between serum chloride and mortality in ICU patients with heart failure: The impact of bicarbonate.
    Int J Cardiol. 2023 Dec 22:131672. doi: 10.1016/j.ijcard.2023.131672.
    >> Share

  50. ADAMO M, Pagnesi M, Di Pasquale M, Ravera A, et al
    Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF.
    Int J Cardiol. 2023 Dec 21:131664. doi: 10.1016/j.ijcard.2023.131664.
    >> Share

  51. WONG CN, Gui XY, Rabkin SW
    Myeloperoxidase, carnitine, and derivatives of reactive oxidative metabolites in heart failure with preserved versus reduced ejection fraction: A meta-analysis.
    Int J Cardiol. 2023 Dec 13:131657. doi: 10.1016/j.ijcard.2023.131657.
    >> Share

  52. OZLEK B
    Tricuspid regurgitation and heart failure with preserved ejection fraction: An enigma in cardiology practice.
    Int J Cardiol. 2023 Dec 10:131649. doi: 10.1016/j.ijcard.2023.131649.
    >> Share

  53. HU H, Yang J
    Heart failure complicated by atrial fibrillation: How to make better choices for anticoagulation?
    Int J Cardiol. 2023 Dec 6:131644. doi: 10.1016/j.ijcard.2023.131644.
    >> Share

  54. ELIA E, Bruno F, Crimi G, Wanha W, et al
    Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry.
    Int J Cardiol. 2023 Dec 5:131622. doi: 10.1016/j.ijcard.2023.131622.
    >> Share

  55. GAO Y, Liu M, Ju Z, Wang H, et al
    Entropy as a novel predictor of cardiovascular events in patients with left ventricular noncompaction.
    Int J Cardiol. 2023;392:131279.
    >> Share

    November 2023
  56. JIN C, Chen G, Zhao C, Wu Y, et al
    First-phase ejection fraction to predict adverse outcomes in patients with heart failure.
    Int J Cardiol. 2023 Nov 30:131612. doi: 10.1016/j.ijcard.2023.131612.
    >> Share

  57. CHOI HM, Hwang IC, Choi HJ, Yoon YE, et al
    Irreversible myocardial injury attenuates the benefits of sacubitril/valsartan in heart failure patients.
    Int J Cardiol. 2023 Nov 27:131611. doi: 10.1016/j.ijcard.2023.131611.
    >> Share

  58. MORONI F, Corna G, Del Buono MG, Golino M, et al
    Impact of C-reactive protein levels and role of anakinra in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2023 Nov 26:131610. doi: 10.1016/j.ijcard.2023.131610.
    >> Share

  59. TAYAL B, Rorth R, Kristensen SL, Wissenberg M, et al
    Comparative outcomes in patients with preexisting heart failure to those without heart failure after out-of-hospital cardiac arrest: A nationwide registry study.
    Int J Cardiol. 2023 Nov 18:131595. doi: 10.1016/j.ijcard.2023.131595.
    >> Share

  60. ALEXANDRINO FB, Faaborg-Andersen CC, da Silva-de Abreu A
    Anticoagulation in patients with atrial fibrillation and heart failure: More than meets the eye?
    Int J Cardiol. 2023 Nov 16:131591. doi: 10.1016/j.ijcard.2023.131591.
    >> Share

  61. LAU ATC, DiDomenico RJ, Kim K
    Cost-effectiveness of systematic screening and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in patients with Heart failure with preserved ejection fraction (HFpEF) in United States.
    Int J Cardiol. 2023 Nov 16:131598. doi: 10.1016/j.ijcard.2023.131598.
    >> Share

  62. ROSSI VA, Laptseva N, Nebunu D, Haider T, et al
    Impaired retinal micro-vascular function in patients with atrial fibrillation.
    Int J Cardiol. 2023 Nov 16:131592. doi: 10.1016/j.ijcard.2023.131592.
    >> Share

  63. D'AMARIO D, Laborante R, Bianchini E, Galli M, et al
    Statins as preventive therapy for anthracycline cardiotoxicity: a meta-analysis of randomized controlled trials.
    Int J Cardiol. 2023;391:131219.
    >> Share

  64. CHAVALI S, Barua S, Adji A, Robson D, et al
    Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in bridge-to-transplant patients supported with centrifugal-flow left ventricular assist devices.
    Int J Cardiol. 2023;391:131259.
    >> Share

  65. LI ZH, Zhong WF, Qiu CS, Yang P, et al
    Association between regular proton pump inhibitors use and cardiovascular outcomes: A large prospective cohort study.
    Int J Cardiol. 2023 Nov 5:131567. doi: 10.1016/j.ijcard.2023.131567.
    >> Share

  66. DORES H, Toste A, Cardim N
    Hypertrophic cardiomyopathy in patients with a normal electrocardiogram: A view from the east side of the Atlantic Ocean.
    Int J Cardiol. 2023;390:131260.
    >> Share

    October 2023
  67. MASE M, Rossi M, Setti M, Barbati G, et al
    Applicability and performance of heart failure prognostic scores in dilated cardiomyopathy: The real-world experience of an Italian referral center for cardiomyopathies.
    Int J Cardiol. 2023 Oct 29:131562. doi: 10.1016/j.ijcard.2023.131562.
    >> Share

  68. KOSEOGLU FD, Ozlek B
    Hemoglobin to red cell distribution width ratio in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Oct 27:131556. doi: 10.1016/j.ijcard.2023.131556.
    >> Share

  69. SERAFIN A, Jasic-Szpak E, Marwick TH, Przewlocka-Kosmala M, et al
    Contribution of reduced skeletal muscle perfusion reserve to exercise intolerance in heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Oct 21:131553. doi: 10.1016/j.ijcard.2023.131553.
    >> Share

  70. SERI A, Rabadi A, Baral N, Andi K, et al
    Prevalence of respiratory failure and use of mechanical ventilation in heart failure patients undergoing left atrial appendage occlusion device implantation.
    Int J Cardiol. 2023 Oct 21:131552. doi: 10.1016/j.ijcard.2023.131552.
    >> Share

  71. ZITO A, Restivo A, D'Amario D
    Reply to "Comment on: Heart failure management guided by remote multiparameter monitoring: A meta-analysis".
    Int J Cardiol. 2023 Oct 20:131545. doi: 10.1016/j.ijcard.2023.131545.
    >> Share

  72. ANSARI RAMANDI MM, Yarmohammadi H, Gareb B, Voors AA, et al
    Long-term outcome of patients with transposition of the great arteries and a systemic right ventricle: A systematic review and meta-analysis.
    Int J Cardiol. 2023;389:131159.
    >> Share

  73. JAIN SS, Yu J, Arnott C, Neal B, et al
    Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial.
    Int J Cardiol. 2023 Oct 14:131444. doi: 10.1016/j.ijcard.2023.131444.
    >> Share

  74. IMANISHI J, Iwasaki M, Ujiro S, Nakano T, et al
    Accuracy of lung ultrasound examinations of residual congestion performed by novice residents in patients with acute heart failure.
    Int J Cardiol. 2023 Oct 14:131446. doi: 10.1016/j.ijcard.2023.131446.
    >> Share

  75. LEONARDI D, Bursi F, Fanti D, Dotto A, et al
    Outpatient tricuspid regurgitation in the community: Clinical context and outcome.
    Int J Cardiol. 2023 Oct 14:131443. doi: 10.1016/j.ijcard.2023.131443.
    >> Share

  76. MOCKEL M, Pudasaini S, Baberg HT, Levenson B, et al
    Oral anticoagulation in heart failure complicated by atrial fibrillation: A nationwide routine data study.
    Int J Cardiol. 2023 Oct 10:131434. doi: 10.1016/j.ijcard.2023.131434.
    >> Share

  77. ROONGSANGMANOON W, Wongsoasup A, Chichareon P, Suwannasom P, et al
    Validation of the academic research consortium high bleeding risk definition in Thai PCI registry.
    Int J Cardiol. 2023;388:131167.
    >> Share

    September 2023
  78. ZHENG H, Yin Z, Luo X, Zhou Y, et al
    Associations between systemic immunity-inflammation index and heart failure: Evidence from the NHANES 1999-2018.
    Int J Cardiol. 2023 Sep 26:131400. doi: 10.1016/j.ijcard.2023.131400.
    >> Share

  79. FONDERICO C, Pergola V, Faccenda D, Salucci A, et al
    Impact of sacubitril/valsartan and gliflozins on cardiac resynchronization therapy response in ischemic and non-ischemic heart failure patients.
    Int J Cardiol. 2023 Sep 23:131391. doi: 10.1016/j.ijcard.2023.131391.
    >> Share

  80. BAUMHOVE L, Bomer N, Tromp J, van Essen BJ, et al
    Clinical characteristics and prognosis of patients with heart failure and high concentrations of interleukin-17D.
    Int J Cardiol. 2023 Sep 21:131384. doi: 10.1016/j.ijcard.2023.131384.
    >> Share

  81. CHEN H, Zhen Z, Dong Y, Liu C, et al
    Hemoglobin to red cell distribution width ratio: A predictor of clinical outcome and diuretic response in patients with acute heart failure.
    Int J Cardiol. 2023 Sep 20:131368. doi: 10.1016/j.ijcard.2023.131368.
    >> Share

  82. LI T, Li Z, Guo S, Jiang S, et al
    The value of using left ventricular pressure-strain loops to evaluate myocardial work in predicting heart failure with improved ejection fraction.
    Int J Cardiol. 2023 Sep 19:131366. doi: 10.1016/j.ijcard.2023.131366.
    >> Share

  83. ANDI K, Abozied O, Miranda WR, Anderson JH, et al
    Clinical benefits of angiotensin receptor-Neprilysin inhibitor in adults with congenital heart disease.
    Int J Cardiol. 2023;387:131152.
    >> Share

  84. TSABEDZE N, Mpanya D, Bailly C, Nel S, et al
    Clinical characteristics and one-year all-cause mortality outcomes in Africans with dilated cardiomyopathy.
    Int J Cardiol. 2023;387:131142.
    >> Share

  85. LEE YH, Kim SM, Kim EK, Park SJ, et al
    Pattern of pericardial calcification determines mid-term postoperative outcomes after pericardiectomy in chronic constrictive pericarditis.
    Int J Cardiol. 2023;387:131133.
    >> Share

  86. ZHANG TY, An DA, Zhou H, Ni Z, et al
    Fractal analysis: Left ventricular trabecular complexity cardiac MRI adds independent risks for heart failure with preserved ejection fraction in participants with end-stage renal disease.
    Int J Cardiol. 2023 Sep 9:131334. doi: 10.1016/j.ijcard.2023.131334.
    >> Share

  87. LEE K, Jung JH, Kwon W, Ohn C, et al
    The prognostic value of cardiopulmonary exercise testing and HFA-PEFF in patients with unexplained dyspnea and preserved left ventricular ejection fraction.
    Int J Cardiol. 2023;386:74-82.
    >> Share

    August 2023
  88. KHAZAEI S, Jenabi E
    Comment on: Heart failure management guided by remote multiparameter monitoring: A meta-analysis.
    Int J Cardiol. 2023 Aug 22:131281. doi: 10.1016/j.ijcard.2023.131281.
    >> Share

  89. PUST F, Deis T, Larsson J, Hansen BL, et al
    Importance of heart failure duration for development of pulmonary hypertension in advanced heart failure.
    Int J Cardiol. 2023 Aug 19:131232. doi: 10.1016/j.ijcard.2023.131232.
    >> Share

  90. CHO Y, Ueda T, Kotani S, Okada K, et al
    AATS 2023: Left ventricular restoration with scar exclusion in the surgical treatment for ischemic heart failure.
    Int J Cardiol. 2023 Aug 18:131277. doi: 10.1016/j.ijcard.2023.131277.
    >> Share

  91. DOGAR ME, Azeem B, Asim R
    Comment on SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice.
    Int J Cardiol. 2023 Aug 9:131255. doi: 10.1016/j.ijcard.2023.131255.
    >> Share

  92. LO JJ, Tromp J, Ouwerkwerk W, Ong MEH, et al
    Examining predictors for 6-month mortality and healthcare utilization for patients admitted for heart failure in the acute care setting.
    Int J Cardiol. 2023 Aug 1:131237. doi: 10.1016/j.ijcard.2023.131237.
    >> Share

    July 2023
  93. SANCHIS L, Farrero M
    Edge to edge mitral valve repair beyond COAPT criteria: A bridge to further therapies for patients with advanced heart failure.
    Int J Cardiol. 2023 Jul 31:131235. doi: 10.1016/j.ijcard.2023.131235.
    >> Share

  94. DE CLERCQ L, Er A, Handoko ML, van Weert HCPM, et al
    Characteristics of heart failure in the Amsterdam metropolitan area (AMSTERDAM-HF): Data from a dynamic general practice cohort (2011-2021).
    Int J Cardiol. 2023 Jul 25:131217. doi: 10.1016/j.ijcard.2023.131217.
    >> Share

  95. TAVERAS HIRALDO A, Canahuate Rodriguez G
    Predicting heart failure rollback.
    Int J Cardiol. 2023 Jul 20:131197. doi: 10.1016/j.ijcard.2023.131197.
    >> Share

  96. JONG CB, Lu TS, Chen TY, Chen CK, et al
    Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome.
    Int J Cardiol. 2023 Jul 18:131195. doi: 10.1016/j.ijcard.2023.131195.
    >> Share

  97. PAVLOV M, Vidak M
    Safety of benzodiazepines in patients with acute heart failure: Questions to be answered.
    Int J Cardiol. 2023 Jul 14:131191. doi: 10.1016/j.ijcard.2023.131191.
    >> Share

  98. ICHIHARA YK, Shiraishi Y, Kohsaka S, Nakano S, et al
    Association of pre-hospital precipitating factors with short- and long-term outcomes of acute heart failure patients: A report from the WET-HF2 registry.
    Int J Cardiol. 2023 Jul 10:131161. doi: 10.1016/j.ijcard.2023.131161.
    >> Share

  99. ZITO A, Restivo A, Ciliberti G, Laborante R, et al
    Heart failure management guided by remote multiparameter monitoring: A meta-analysis.
    Int J Cardiol. 2023 Jul 8:131163. doi: 10.1016/j.ijcard.2023.131163.
    >> Share

  100. SUN Y, Wang C, Ren J
    CRT upgrading might be a potential therapy in pacemaker-induced cardiomyopathy.
    Int J Cardiol. 2023;382:62.
    >> Share

  101. WANG RJ, Xu C, Tang HF
    A cardiovascular polypharmacy perspective on octogenarians with HFpEF.
    Int J Cardiol. 2023;382:60-61.
    >> Share

    June 2023
  102. CASTIGLIONE V, Gentile F, Vergaro G
    Cachexia, sarcopenia and heart failure: A last mile to be walked.
    Int J Cardiol. 2023 Jun 24:131131. doi: 10.1016/j.ijcard.2023.131131.
    >> Share

  103. MORITA K, Miyamoto Y, Mizuno A, Shirane S, et al
    Impact of a financial incentive scheme for team-based palliative care in patients with heart failure in Japan: A nationwide database study.
    Int J Cardiol. 2023 Jun 24:131145. doi: 10.1016/j.ijcard.2023.131145.
    >> Share

  104. MARGONATO D, Ancona F, Cesari A, Ghantous E, et al
    The long-term clinical course of moderate tricuspid regurgitation.
    Int J Cardiol. 2023 Jun 24:131135. doi: 10.1016/j.ijcard.2023.131135.
    >> Share

  105. MUNAFO AR, Scotti A, Estevez-Loureiro R, Adamo M, et al
    2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry.
    Int J Cardiol. 2023 Jun 22:131139. doi: 10.1016/j.ijcard.2023.131139.
    >> Share

  106. GALATI G, Germanova O, Pedretti RFE, Ambrosio G, et al
    Hypotension and optimization of heart failure therapy after a recent hospitalization for heart failure: When the going gets tough, the tough get going.
    Int J Cardiol. 2023 Jun 13:131118. doi: 10.1016/j.ijcard.2023.131118.
    >> Share

  107. CAMILLI M, Iannaccone G, Russo M, Meucci MC, et al
    Early improvement of strain imaging parameters predicts long-term response to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: An observational prospective study.
    Int J Cardiol. 2023 Jun 6:S0167-5273(23)00835.
    >> Share

    May 2023
  108. ZHANG X, Lv X, Wang N, Yu S, et al
    WATCH-DM risk score predicts the prognosis of diabetic phenotype patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2023 May 29:S0167-5273(23)00738.
    >> Share

  109. MUTOLI M, Martelli F, Spinetti G
    TfR1 gene expression as a potential biomarker for iron deficiency in heart failure.
    Int J Cardiol. 2023 May 23:S0167-5273(23)00722.
    >> Share

  110. WU L, Wu M, Zhang X, Chen S, et al
    Increased arterial stiffness elevates the risk of heart failure in diabetic patients.
    Int J Cardiol. 2023 May 23:S0167-5273(23)00732.
    >> Share

  111. ANGELICO-GONCALVES A, Leite AR, Neves JS, Saraiva F, et al
    Changes in health-related quality of life and treatment effects in chronic heart failure: A meta-analysis.
    Int J Cardiol. 2023 May 19:S0167-5273(23)00726.
    >> Share

  112. MEIJS C, Brugts JJ, Lund LH, Linssen GCM, et al
    Identifying distinct clinical clusters in heart failure with mildly reduced ejection fraction.
    Int J Cardiol. 2023 May 16:S0167-5273(23)00718.
    >> Share

  113. CABRERA C, Frisk C, Lofstrom U, Lynga P, et al
    Relationship between iron deficiency and expression of genes involved in iron metabolism in human myocardium and skeletal muscle.
    Int J Cardiol. 2023;379:82-88.
    >> Share

  114. KUCHTARUK AA, Sparrow RT, Azzalini L, Garcia S, et al
    Unplanned readmissions after Impella mechanical circulatory support.
    Int J Cardiol. 2023;379:48-59.
    >> Share

  115. ALHAKAK AS, Olsen FJ, Skaarup KG, Lassen MCH, et al
    Changes in cardiac time intervals over a decade and the risk of incident heart failure: The Copenhagen City heart study.
    Int J Cardiol. 2023 May 11:S0167-5273(23)00709.
    >> Share

  116. MELENDO-VIU M, Dobarro D, Lopez AM, Dominguez LM, et al
    Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?
    Int J Cardiol. 2023 May 9:S0167-5273(23)00658.
    >> Share

  117. MAGRI D, Palermo P, Salvioni E, Mapelli M, et al
    Influence of exertional oscillatory breathing and its temporal behavior in patients with heart failure and reduced ejection fraction.
    Int J Cardiol. 2023 May 8:S0167-5273(23)00659.
    >> Share

  118. FRANCESCO A, Davide M, Gregorio M, Matteo B, et al
    Ratio between right ventricular longitudinal strain and pulmonary arterial systolic pressure: A novel prognostic parameter in patients with severe tricuspid regurgitation.
    Int J Cardiol. 2023 May 4:S0167-5273(23)00647.
    >> Share

  119. KOH SJQ, Yap J, Jiang Y, Sng GGR, et al
    Clinical outcomes in end stage renal disease on dialysis and severe coronary artery disease: A real-world study.
    Int J Cardiol. 2023;378:105-110.
    >> Share

    April 2023
  120. ASAUMI Y
    Peripheral vein pressure as a less-invasive marker at the vulnerable phase after hospitalization of heart failure.
    Int J Cardiol. 2023 Apr 28:S0167-5273(23)00593.
    >> Share

  121. BOTTIROLI M, Calini A, Morici N, Tavazzi G, et al
    Acute kidney injury in patients with acute decompensated heart failure-cardiogenic shock: Prevalence, risk factors and outcome.
    Int J Cardiol. 2023 Apr 28:S0167-5273(23)00612.
    >> Share

  122. ZEITOUNI M, Morlon Q, Silvain J, Procopi N, et al
    Implication of the new definition of pulmonary hypertension in patients evaluated for heart transplantation.
    Int J Cardiol. 2023 Apr 27:S0167-5273(23)00602.
    >> Share

  123. SINGAM NSV, Tabi M, Wiley B, Anavekar N, et al
    Echocardiographic findings in cardiogenic shock due to acute myocardial infarction versus heart failure.
    Int J Cardiol. 2023 Apr 26:S0167-5273(23)00595.
    >> Share

  124. NISHINO M, Egami Y, Yamada T, Yasumura Y, et al
    Reply to "Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction".
    Int J Cardiol. 2023 Apr 17:S0167-5273(23)00536.
    >> Share

  125. FERREIRA JP, Cleland JG, Girerd N, Rossignol P, et al
    Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials.
    Int J Cardiol. 2023;377:86-88.
    >> Share

  126. CHRISTOPH M, Marius S, Karl S, Friedrich K, et al
    Efficacy of CRT upgrade in pacemaker-induced cardiomyopathy in an outpatient clinic - Results of a prospective registry.
    Int J Cardiol. 2023;377:60-65.
    >> Share

  127. YANG Q, Wu H, Liu D, Li Y, et al
    Discussion of a study on the role of EMS in prognosis of elderly patients with AHF.
    Int J Cardiol. 2023;377:91.
    >> Share

  128. SALAMANCA-BAUTISTA P, Romero-Correa M, Formiga F, Antequera-Martin-Portugues I, et al
    Safety of benzodiazepines in patients with acute heart failure: A propensity score-matching study.
    Int J Cardiol. 2023 Apr 14:S0167-5273(23)00529.
    >> Share

  129. EDER M, Griffin M, Moreno-Villagomez J, Bellumkonda L, et al
    The importance of forward flow and venous congestion in diuretic response in acute heart failure: Insights from the ESCAPE trial.
    Int J Cardiol. 2023 Apr 4:S0167-5273(23)00517.
    >> Share

    March 2023
  130. LUO Q, Zhuang B, Li G, Jiang Y, et al
    Consistency evaluation of exercise target heart rate determined by resting heart rate and anaerobic threshold in chronic heart failure patients.
    Int J Cardiol. 2023 Mar 29:S0167-5273(23)00467.
    >> Share

  131. HORTEGAL RA, Valeri R, Grizante M, Cancellier R, et al
    Afterload increase challenge unmasks systolic abnormalities in heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Mar 21:S0167-5273(23)00453.
    >> Share

  132. FUJIMOTO Y, Maeda D, Kagiyama N, Sunayama T, et al
    Prevalence and prognostic impact of the coexistence of cachexia and sarcopenia in older patients with heart failure.
    Int J Cardiol. 2023 Mar 17:S0167-5273(23)00447.
    >> Share

  133. TAKIMURA H, Taniguchi R, Tsuzuki I, Tajima E, et al
    Impact of the time-to-target rate of urine volume concept on the outcome of acute decompensated heart failure.
    Int J Cardiol. 2023 Mar 17:S0167-5273(23)00445.
    >> Share

  134. KUMAR HU, Nearing BD, Mittal S, Premchand RK, et al
    Autonomic regulation therapy in chronic heart failure with preserved/mildly reduced ejection fraction: ANTHEM-HFpEF study results.
    Int J Cardiol. 2023 Mar 17:S0167-5273(23)00440.
    >> Share

  135. ZHANG HD, Yan Y, He YY, Liu QQ, et al
    Characteristics of exercise intolerance in different subgroups of pulmonary arterial hypertension associated with congenital heart disease.
    Int J Cardiol. 2023;375:29-35.
    >> Share

  136. LI X, Shen Y, Xu X, Guo G, et al
    Genomic and RNA-Seq profiling of patients with HFrEF unraveled OAS1 mutation and aggressive expression.
    Int J Cardiol. 2023;375:44-54.
    >> Share

  137. FUJIMOTO Y, Maeda D, Kagiyama N, Sunayama T, et al
    Prognostic implications of six-minute walking distance in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Mar 11:S0167-5273(23)00396.
    >> Share

  138. BURGER PM, Koudstaal S, Dorresteijn JAN, Savarese G, et al
    Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease.
    Int J Cardiol. 2023 Mar 11:S0167-5273(23)00395.
    >> Share

  139. HEEGAARD B, Deis T, Rossing K, Ersboll M, et al
    Diabetes mellitus and hemodynamics in advanced heart failure.
    Int J Cardiol. 2023 Mar 10:S0167-5273(23)00341.
    >> Share

  140. KAWAJI T, Shiomi H, Bao B, Hojo S, et al
    Intracardiac energy inefficiency during atrial fibrillation rhythm with heart failure: Assessment by echo-vector flow mapping.
    Int J Cardiol. 2023 Mar 10:S0167-5273(23)00392.
    >> Share

  141. DURAN A, Ventura HO
    The value of frequent objective risk assessments in heart failure management.
    Int J Cardiol. 2023 Mar 6:S0167-5273(23)00333.
    >> Share

  142. MOHEBI R, Liu Y, Murphy SP, Gaggin HK, et al
    Clinical profiling of end-stage heart failure with preserved ejection fraction: The National Readmission Database.
    Int J Cardiol. 2023 Mar 2:S0167-5273(23)00269.
    >> Share

  143. ZAMPIERI M, Salvi S, Fumagalli C, Argiro A, et al
    Clinical scenarios of hypertrophic cardiomyopathy-related mortality: Relevance of age and stage of disease at presentation.
    Int J Cardiol. 2023;374:65-72.
    >> Share

  144. LIU Y, Li Y, Zhang J, Zhao Y, et al
    Pregnancy outcomes of women with Eisenmenger syndrome: A single-center study.
    Int J Cardiol. 2023;374:35-41.
    >> Share

    February 2023
  145. DIEZ MPL, Alquezar-Arbe A, Jacob J, Llorens P, et al
    Hospital development of heart failure follow-up units and short-term prognosis after acute decompensation in Spain.
    Int J Cardiol. 2023 Feb 17:S0167-5273(23)00247.
    >> Share

  146. SEFEROVIC PM, Polovina M, Seferovic J, Rosano G, et al
    Corrigendum to "Strength in synergy: Cardiometabolic effects of sacubitril/valsartan in heart failure and diabetes" [International Journal of Cardiology 2023 Jan 15;371:293-294 10.1016/j.ijcard.2022.09.019.
    Int J Cardiol. 2023 Feb 16:S0167-5273(23)00232.
    >> Share

  147. XING C, Wang X, Pan X, Yu J, et al
    Outcomes of atrial septostomy and effect on long-term survival in patients with idiopathic pulmonary arterial hypertension: A single-center cohort.
    Int J Cardiol. 2023;373:118-123.
    >> Share

  148. SHIROTANI S, Jujo K, Takada T, Abe T, et al
    Renin-angiotensin system inhibitor exerts prognostic effects in HFpEF patients with low baseline chloride level.
    Int J Cardiol. 2023;373:83-89.
    >> Share

  149. NISHINO M, Egami Y, Kawanami S, Sugae H, et al
    Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Feb 14:S0167-5273(23)00237.
    >> Share

  150. KERSTENS TP, Weerts J, van Dijk APJ, Weijers G, et al
    Left ventricular strain-volume loops and diastolic dysfunction in suspected heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Feb 14:S0167-5273(23)00167.
    >> Share

  151. YANAGISAWA S, Inden Y, Murohara T
    Catheter ablation for atrial fibrillation in heart failure: Getting closer to the full picture in the whole population.
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00226.
    >> Share

  152. GOES-SANTOS BR, Rondon E, Fonseca GWP, Sales ARK, et al
    Physical capacity increase in patients with heart failure is associated with improvement in muscle sympathetic nerve activity.
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00234.
    >> Share

  153. CAMPBELL-QUINTERO S, Echeverria LE, Gomez-Mesa JE, Rivera-Toquica A, et al
    Comorbidity profile and outcomes in patients with chronic heart failure in a Latin American country: Insights from the Colombian heart failure registry (RECOLFACA).
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00236.
    >> Share

  154. KOSTANJSEK L, Ardissino M, Moussa O, Rayes B, et al
    Effect of bariatric surgery on the incidence of heart failure: A propensity score matched nationwide cohort study.
    Int J Cardiol. 2023 Feb 2:S0167-5273(23)00169.
    >> Share

    January 2023
  155. NGUYEN BN, Mital S, Bugden S, Nguyen HV, et al
    Cost-effectiveness of dapagliflozin and empagliflozin for treatment of heart failure with reduced ejection fraction.
    Int J Cardiol. 2023 Jan 31:S0167-5273(23)00120.
    >> Share

  156. PEZZUTO B, Piepoli M, Galotta A, Sciomer S, et al
    The importance of re-evaluating the risk score in heart failure patients: An analysis from the Metabolic Exercise Cardiac Kidney Indexes (MECKI) score database.
    Int J Cardiol. 2023 Jan 27:S0167-5273(23)00110.
    >> Share

  157. WERNHART S, Papathanasiou M, Rassaf T, Luedike P, et al
    Heart failure classification based on resting ejection fraction does not display a unique exercise response pattern.
    Int J Cardiol. 2023 Jan 27:S0167-5273(23)00113.
    >> Share

  158. CASULA M, Pignalosa L, Quilico F, Scajola LV, et al
    A comprehensive meta-analysis comparing radiofrequency ablation versus pharmacological therapy for the treatment of atrial fibrillation in patients with heart failure.
    Int J Cardiol. 2023 Jan 26:S0167-5273(23)00111.
    >> Share

  159. CANEPA M, Leporatti L, Persico L, Ameri P, et al
    Corrigendum to "Frequency, characteristics and prognostic impact of hospital readmissions in elderly patients with heart failure: A population study from 2013 to 2017 in Liguria, Northern Italy" [Int J Cardiol. 2022 Sep 15;363:111-118].
    Int J Cardiol. 2023 Jan 20:S0167-5273(23)00057.
    >> Share

  160. KONG G, Chin YH, Chong B, Goh RSJ, et al
    Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: Results from a global meta-analysis of 1,285,722 patients.
    Int J Cardiol. 2023;371:432-440.
    >> Share

  161. KIRSCH M, Feriel M, Aurelia LT, Oksana K, et al
    Impact of training on combined cardiopulmonary exercise test with stress echocardiography parameters in HFrEF patients.
    Int J Cardiol. 2023;371:252-258.
    >> Share

  162. TOTO F, Salvioni E, Magri D, Sciomer S, et al
    Does moderate hyperkalemia influence survival in HF? Insights from the MECKI score data base.
    Int J Cardiol. 2023;371:273-277.
    >> Share

  163. LIANG J, Zhang Z
    Predictors of in-hospital heart failure in patients with acute anterior wall ST-segment elevation myocardial infarction.
    Int J Cardiol. 2023 Jan 10:S0167-5273(23)00043.
    >> Share

  164. MIYAMOTO R, Nagao K, Matsuto K, Hata R, et al
    Relationship between atrial fibrillation and a liver fibrogenesis marker in patients with acute heart failure.
    Int J Cardiol. 2023 Jan 10:S0167-5273(23)00001.
    >> Share

  165. IWAHASHI N
    Right ventricular strain and mechanical dispersion for heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Jan 5:S0167-5273(22)01977.
    >> Share

  166. MATSUTO K, Maruichi-Kawakami S, Aida K, Imamoto K, et al
    Prognostic implications of post-discharge hemodynamic congestion assessed by peripheral venous pressure among patients discharged from acute heart failure.
    Int J Cardiol. 2023 Jan 4:S0167-5273(22)01982.
    >> Share

  167. GALASSI A, Cara A, Magagnoli L, Faccioli FM, et al
    Do SGLT2 inhibitors protect elderly patients from HF rehospitalization and CKD progression? More opportunities than concerns.
    Int J Cardiol. 2023;370:321-322.
    >> Share

  168. TROMBARA F, Alimento ML
    Should we be afraid of moderate hyperkalemia in HFrEF outpatients?
    Int J Cardiol. 2023;370:323-324.
    >> Share

  169. ZANNONI J, Guazzi M, Milani V, Bandera F, et al
    Prognostic value of cardiopulmonary exercise testing in a European cohort with cardiovascular risk factors absent of a cardiovascular disease diagnosis.
    Int J Cardiol. 2023;370:402-404.
    >> Share

  170. LUND LH, Zeymer U, Clark AL, Barrios V, et al
    Association between sacubitril/valsartan initiation and changes in left ventricular ejection fraction: Insights from ARIADNE registry.
    Int J Cardiol. 2023;370:279-286.
    >> Share

    December 2022
  171. KOBAYASHI M, Ferreira JP, Matsue Y, Chikamori T, et al
    Effect of eplerenone on clinical stability of Japanese patients with acute heart failure.
    Int J Cardiol. 2022 Dec 28:S0167-5273(22)01938.
    >> Share

  172. KURASHIMA S, Kitai T, Matsue Y, Nogi K, et al
    Trajectory of serum chloride levels during decongestive therapy in acute heart failure.
    Int J Cardiol. 2022 Dec 27:S0167-5273(22)01933.
    >> Share

  173. AMPARO TAVERAS H
    The dilemma of thromboembolism prophylaxis in patient with acute heart failure.
    Int J Cardiol. 2022 Dec 16:S0167-5273(22)01913.
    >> Share

  174. JUG B
    Heart failure with reduced ejection fraction and low blood pressure: Overcoming another barrier to guideline-directed medical therapy?
    Int J Cardiol. 2022 Dec 8:S0167-5273(22)01882.
    >> Share

  175. KAUR G, Jones M, Howes L, Hattingh HL, et al
    Systematic review and meta-analysis of the association between all-cause mortality and statin therapy in patients with preserved ejection fraction heart failure (HFpEF).
    Int J Cardiol. 2022 Dec 7:S0167-5273(22)01871.
    >> Share

  176. WEWER ALBRECHTSEN NJ, Bojsen-Moller KN
    Letter to the Editor regarding to 'Activation of GLP-1 receptor signalling by sacubitril/valsartan: Implications for patients with poor glycaemic control'.
    Int J Cardiol. 2022;368:55.
    >> Share

    November 2022
  177. SEPHIEN A, Ghobrial M, Reljic T, Prida X, et al
    Efficacy of SGLT2 inhibitors in patients with heart failure: An overview of systematic reviews.
    Int J Cardiol. 2022 Nov 28:S0167-5273(22)01739.
    >> Share

  178. VAN BERGEIJK KH, Wykrzykowska JJ, Sartori S, Snyder C, et al
    Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort.
    Int J Cardiol. 2022 Nov 28:S0167-5273(22)01743.
    >> Share

  179. KANG Y, Hwang HY
    Carbohydrate antigen 125; A biomarker not only for medical patients but also for surgical patients with heart failure.
    Int J Cardiol. 2022 Nov 26:S0167-5273(22)01733.
    >> Share

  180. DU Y, Yuan N, Yan J, Han G, et al
    Identification of echocardiographic subgroups in patients with coronary heart disease combined with heart failure based on latent variable stratification.
    Int J Cardiol. 2022 Nov 25:S0167-5273(22)01725.
    >> Share

  181. MAHTANI K, Patel B, Wang B, Barron A, et al
    Activation of GLP-1 receptor signalling by sacubitril/valsartan: Implications for patients with poor glycaemic control.
    Int J Cardiol. 2022;367:81-89.
    >> Share

  182. HAMATANI Y, Kato T, Morimoto T, Iguchi M, et al
    Association of intravenous heparin administration with in-hospital clinical outcomes among hospitalized patients with acute heart failure.
    Int J Cardiol. 2022 Nov 11. pii: S0167-5273(22)01705.
    >> Share

  183. CAI J, Zhang L, Chen C, Ge J, et al
    Association between serum klotho concentration and heart failure in adults, a cross-sectional study from NHANES 2007-2016.
    Int J Cardiol. 2022 Nov 6. pii: S0167-5273(22)01697.
    >> Share

  184. PASQUALIN G, Chessa M
    HFpEF, HFmEF, HFrEF in adults with congenital heart disease: Time to face it.
    Int J Cardiol. 2022;366:19.
    >> Share

  185. GOMEZ-HOSPITAL JA, Ferreiro JL
    Percutaneous circulatory support in high-risk PCI: Pulsatile or continuous flow devices?
    Int J Cardiol. 2022;366:80-81.
    >> Share

    October 2022
  186. SHANAH L, Mir T, Uddin MM, Hussain T, et al
    Clinical outcomes and 30-day readmissions for heart failure with reduced ejection fraction with cardiorenal syndrome: A National Cohort Study.
    Int J Cardiol. 2022 Oct 31. pii: S0167-5273(22)01672.
    >> Share

  187. DE FILIPPO O, D'Ascenzo F, Wojciech W, Leonardi S, et al
    IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry.
    Int J Cardiol. 2022 Oct 25. pii: S0167-5273(22)01658.
    >> Share

  188. FAABORG-ANDERSEN CC, daSilva-deAbreu A, Ventura HO
    Optimized dosing of guideline-directed medical therapies is essential in heart failure with reduced ejection fraction.
    Int J Cardiol. 2022 Oct 20. pii: S0167-5273(22)01648.
    >> Share

  189. BEREZIN AE
    Heart failure with recovered ejection fraction: The role of HbA1c level in hospitalized heart failure patients with type 2 diabetes.
    Int J Cardiol. 2022 Oct 19. pii: S0167-5273(22)01531.
    >> Share

  190. KANEKO T, Kagiyama N, Nakamura Y, Dotare T, et al
    External validation of the ACUTE HF score for risk stratification in acute heart failure.
    Int J Cardiol. 2022 Oct 18. pii: S0167-5273(22)01641.
    >> Share

  191. KISHIHARA M, Takada T, Jujo K, Shirotani S, et al
    Prognostic impact of guideline-directed medical therapy in patients with heart failure on regular hemodialysis.
    Int J Cardiol. 2022 Oct 18. pii: S0167-5273(22)01642.
    >> Share

  192. IZUMI K, Kohno T, Goda A, Takeuchi S, et al
    Low blood pressure and guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.
    Int J Cardiol. 2022 Oct 18. pii: S0167-5273(22)01640.
    >> Share

  193. TAKEUCHI S, Kohno T, Goda A, Shiraishi Y, et al
    Malnutrition in real-world patients hospitalized for heart failure with preserved ejection fraction and its potential impact on generalizability of EMPEROR-Preserved trial.
    Int J Cardiol. 2022 Oct 15. pii: S0167-5273(22)01533.
    >> Share

  194. PROFF J, Merkely B, Papp R, Lenz C, et al
    Closed loop stimulation in patients with chronic heart failure and severe chronotropic incompetence: Responders versus non-responders.
    Int J Cardiol. 2022 Oct 12. pii: S0167-5273(22)01530.
    >> Share

  195. SIMON W, Maria P, Mahabadi AA, Tienush R, et al
    Betablockers reduce oxygen pulse increase and performance in heart failure patients with preserved ejection fraction.
    Int J Cardiol. 2022 Oct 8. pii: S0167-5273(22)01478.
    >> Share

  196. CHEN A, Geng Z, Zhang Y
    Efficacy and safety of early cardiac rehabilitation for patients with heart failure.
    Int J Cardiol. 2022 Oct 5. pii: S0167-5273(22)01471.
    >> Share

  197. CASTRO-PORTILLO E, Lopez-Izquierdo R, Sanz-Garcia A, Ortega GJ, et al
    Role of prehospital point-of-care N-terminal pro-brain natriuretic peptide in acute life-threatening cardiovascular disease.
    Int J Cardiol. 2022;364:126-132.
    >> Share

    September 2022
  198. LI L, Tu B, Liu S, Zhang Z, et al
    Sex differences in ventricular arrhythmias epidemiology, risk factors, and mortality in congestive heart failure.
    Int J Cardiol. 2022 Sep 28. pii: S0167-5273(22)01415.
    >> Share

  199. PICCINNI C, Dondi L, Calabria S, Ronconi G, et al
    How many and who are patients with heart failure eligible to SGLT2 inhibitors? Responses from the combination of administrative healthcare and primary care databases.
    Int J Cardiol. 2022 Sep 26. pii: S0167-5273(22)01403.
    >> Share

  200. LI X, Zuo C, Chen C, Tian D, et al
    Effectiveness and safety evaluation of sacubitril/valsartan in blood pressure control and clinical outcomes for elderly patients with heart failure and hypertension: A prospective cohort study.
    Int J Cardiol. 2022 Sep 26. pii: S0167-5273(22)01400.
    >> Share

  201. AMIOKA M, Sanada R, Matsumura H, Kinoshita H, et al
    Impact of SGLT2 inhibitors on old age patients with heart failure and chronic kidney disease.
    Int J Cardiol. 2022 Sep 26. pii: S0167-5273(22)01409.
    >> Share

  202. JARJOUR M, Leclerc J, Bouabdallaoui N, Ahnadi C, et al
    Optimization of pharmacotherapies for ambulatory patients with heart failure and reduced ejection fraction is associated with improved outcomes.
    Int J Cardiol. 2022 Sep 26. pii: S0167-5273(22)01408.
    >> Share

  203. ATTAR R, Valentin JB, Andell P, Nielsen RE, et al
    Major adverse cardiovascular events following acute coronary syndrome in patients with bipolar disorder.
    Int J Cardiol. 2022;363:1-5.
    >> Share

  204. STAMATELOPOULOS K, Delialis D, Georgiopoulos G, Tselegkidi MI, et al
    Determining patterns of vascular function and structure in wild-type transthyretin cardiac amyloidosis. A comparative study.
    Int J Cardiol. 2022;363:102-110.
    >> Share

  205. YANG CD, Aihemaiti M, Quan JW, Chen JW, et al
    HbA1c level is associated with the development of heart failure with recovered ejection fraction in hospitalized heart failure patients with type 2 diabetes.
    Int J Cardiol. 2022 Sep 15. pii: S0167-5273(22)01339.
    >> Share

  206. SEFEROVIC PM, Polovina M, Seferovic J, Rosano G, et al
    Strength in synergy: Cardiometabolic effects of sacubitril/valsartan in heart failure and diabetes.
    Int J Cardiol. 2022 Sep 14. pii: S0167-5273(22)01328.
    >> Share

  207. HIGUCHI S, Orban M, Adamo M, Giannini C, et al
    Sex-specific impact of anthropometric parameters on outcomes after transcatheter edge-to-edge repair for secondary mitral regurgitation.
    Int J Cardiol. 2022 Sep 14. pii: S0167-5273(22)01337.
    >> Share

  208. MAHABADI AA, Anapliotis V, Dykun I, Rassaf T, et al
    Response to: Epicardial adipose tissue in heart failure: A promising therapeutic target.
    Int J Cardiol. 2022 Sep 11. pii: S0167-5273(22)01326.
    >> Share

  209. MIAO C, Tang ZW, Nie F
    Epicardial adipose tissue in heart failure: A promising therapeutic target.
    Int J Cardiol. 2022 Sep 11. pii: S0167-5273(22)01327.
    >> Share

  210. PASTORE MC, Mandoli GE, Stefanini A, Ghionzoli N, et al
    Prediction of congestive state in acute and chronic heart failure: The association between NT-proBNP and left atrial strain and its prognostic value.
    Int J Cardiol. 2022 Sep 3. pii: S0167-5273(22)01266.
    >> Share

  211. BURRI H
    Electrical remodeling and super-response with biventricular and conduction system pacing: Can cardiac resynchronization therapy be curative?
    Int J Cardiol. 2022;362:83-84.
    >> Share

  212. KHAZAEI S, Khazaei M
    Comment on: Prognostic implications of staging cardiac remodeling in patients undergoing cardiac resynchronization therapy.
    Int J Cardiol. 2022;362:152.
    >> Share

    August 2022
  213. GIL FR, Brida M
    Response to Letter Regarding Article 'Heart failure in adults with congenital heart disease'.
    Int J Cardiol. 2022 Aug 24. pii: S0167-5273(22)01255.
    >> Share

  214. OGAWA M, Yoshida N, Nakai M, Kanaoka K, et al
    Hospital-associated disability and hospitalization costs for acute heart failure stratified by body mass index- insight from the JROAD/JROAD-DPC database.
    Int J Cardiol. 2022 Aug 24. pii: S0167-5273(22)01254.
    >> Share

  215. GHAJAR A, Ordonez CP, Philips B, Pinzon PQ, et al
    Cardiogenic shock related cardiovascular disease mortality trends in US population: Heart failure vs. acute myocardial infarction as contributing causes.
    Int J Cardiol. 2022 Aug 21. pii: S0167-5273(22)01253.
    >> Share

  216. LI S, Zheng Y, Huang Y, He W, et al
    Association of body mass index and prognosis in patients with HFpEF: A dose-response meta-analysis.
    Int J Cardiol. 2022;361:40-46.
    >> Share

  217. PAPANASTASIOU CA, Bazmpani MA, Kokkinidis DG, Zegkos T, et al
    The prognostic value of right ventricular ejection fraction by cardiovascular magnetic resonance in heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Aug 9. pii: S0167-5273(22)01175.
    >> Share

  218. TSCHOPE C, Nelki V, Trippel TD, Klingel K, et al
    Safety and usefulness of left ventricular endomyocardial biopsy in new- onset acute heart failure requiring mechanical support by an Impella(R) device.
    Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01176.
    >> Share

  219. GARATTI L, Frea S, Bocchino PP, Angelini F, et al
    Sodium nitroprusside in acute heart failure: A multicenter historic cohort study.
    Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01177.
    >> Share

  220. LIM HS
    How does protocolization improve outcomes in cardiogenic shock due to end-stage heart failure?
    Int J Cardiol. 2022 Aug 2. pii: S0167-5273(22)01115.
    >> Share

  221. AIMO A, Lupon J, Spitaleri G, Domingo M, et al
    Global warming, renal function and heart failure over 20years.
    Int J Cardiol. 2022 Aug 1. pii: S0167-5273(22)01113.
    >> Share

    July 2022
  222. TANG SS, Wang XJ, Tang CK
    The authors' reply to the letter "CA125 a cause or an effect in heart failure?"
    Int J Cardiol. 2022 Jul 31. pii: S0167-5273(22)01114.
    >> Share

  223. CHISHIKI T, Nagatomo Y, Saji M, Takei M, et al
    Divergent effect of blood glucose dysregulation on long-term clinical outcome in acute decompensated heart failure: A reappraisal in contemporary practice.
    Int J Cardiol. 2022 Jul 25. pii: S0167-5273(22)01111.
    >> Share

  224. PINTALHAO M, Vasques-Novoa F, Couto-Viana B, Pimentel MJ, et al
    Relaxin-2, pathophysiological insights and outcomes in heart failure with preserved ejection fraction: Findings from the NETDiamond cohort.
    Int J Cardiol. 2022 Jul 20. pii: S0167-5273(22)01106.
    >> Share

  225. AREVALO-LORIDO JC, Carretero-Gomez J
    The circular pathway for the improvement of readmitting heart failure patients.
    Int J Cardiol. 2022 Jul 20. pii: S0167-5273(22)01099.
    >> Share

  226. AUSTIN DE, Lee DS, Wang CX, Ma S, et al
    Comparison of machine learning and the regression-based EHMRG model for predicting early mortality in acute heart failure.
    Int J Cardiol. 2022 Jul 19. pii: S0167-5273(22)01105.
    >> Share

  227. GODINO C, Scotti A, Marengo A, Battini I, et al
    Effectiveness and cost-efficacy of diuretics home administration via peripherally inserted central venous catheter in patients with end-stage heart failure.
    Int J Cardiol. 2022 Jul 16. pii: S0167-5273(22)01095.
    >> Share

  228. MOOLLA M, Mathew A, John K, Yogasundaram H, et al
    Outcomes of pregnancy in women with hypertrophic cardiomyopathy: A systematic review.
    Int J Cardiol. 2022;359:54-60.
    >> Share

  229. CHENG B, Zhong JP, Fu WJ, Chen HJ, et al
    Microfiber-associated protein 5 (MFAP5): A promising approach to discover new biomarkers for heart failure and cardiac remodeling.
    Int J Cardiol. 2022 Jul 7. pii: S0167-5273(22)01033.
    >> Share

  230. SHAMAKI GR, Kesiena O, Markson F, Andrew M, et al
    Editorial of "Heart failure with normal LVEF in BIOSTAT-CHF" to International Journal of Cardiology".
    Int J Cardiol. 2022 Jul 1. pii: S0167-5273(22)01021.
    >> Share

  231. SWARTZ AM, Wamsley C, Crownover E, Tarima S, et al
    Move more and sit less pilot intervention for individuals with heart failure.
    Int J Cardiol. 2022 Jul 1. pii: S0167-5273(22)01023.
    >> Share

    June 2022
  232. YANO M, Nishino M, Ukita K, Kawamura A, et al
    Clinical impact of blood urea nitrogen, regardless of renal function, in heart failure with preserved ejection fraction.
    Int J Cardiol. 2022 Jun 29. pii: S0167-5273(22)01014.
    >> Share

  233. YOUNES AM, Salem M, Maraey A, Nomigolzar S, et al
    Safety outcomes of SGLT2i in the heart failure trials: A systematic review and Meta-analysis.
    Int J Cardiol. 2022 Jun 28. pii: S0167-5273(22)01012.
    >> Share

  234. BAUDO M, D'Ancona G, Trinca F, Rosati F, et al
    Atrioventricular node ablation and pacing for atrial tachyarrhythmias: A meta-analysis of postoperative outcomes.
    Int J Cardiol. 2022 Jun 25. pii: S0167-5273(22)01011.
    >> Share

  235. RABKIN SW
    Heart failure with reduced ejection fraction and diastolic dysfunction (HrEFwDD): Time for a new clinical entity.
    Int J Cardiol. 2022 Jun 24. pii: S0167-5273(22)01008.
    >> Share

  236. KIM SE, Cho DH, Son JW, Kim JY, et al
    Impact of NT-proBNP on prognosis of acute decompensated chronic heart failure versus de novo heart failure.
    Int J Cardiol. 2022 Jun 23. pii: S0167-5273(22)01007.
    >> Share

  237. COWIE MR, Mourilhe-Rocha R, Chang HY, Volterrani M, et al
    The impact of the COVID-19 pandemic on heart failure management: Global experience of the OPTIMIZE heart failure care network.
    Int J Cardiol. 2022 Jun 21. pii: S0167-5273(22)00922.
    >> Share

  238. EPSTEIN E, Schale S, Brambatti M, You H, et al
    Impact of Transitioning Patients to Oral Diuretics 24 Hours Before Discharge from Heart Failure Hospitalization on 30 Day Outcomes.
    Int J Cardiol. 2022 Jun 20. pii: S0167-5273(22)00930.
    >> Share

  239. CANEPA M, Leporatti L, Persico L, Ameri P, et al
    Frequency, characteristics and prognostic impact of hospital readmissions in elderly patients with heart failure: A population study from 2013 to 2017 in Liguria, Northern Italy.
    Int J Cardiol. 2022 Jun 18. pii: S0167-5273(22)00951.
    >> Share

  240. IMRAN TF, Mohebali D, Lopez D, Goli RR, et al
    NT-proBNP and predictors of event free survival and left ventricular systolic function recovery in peripartum cardiomyopathy.
    Int J Cardiol. 2022;357:48-54.
    >> Share

  241. QIAN Z, Qin C, Zou F, Xue S, et al
    Complete electrical reverse remodeling of native conduction after resynchronization therapies.
    Int J Cardiol. 2022;357:81-87.
    >> Share

  242. SEIDEL F, Opgen-Rhein B, Rentzsch A, Boehne M, et al
    Clinical characteristics and outcome of biopsy-proven myocarditis in children - Results of the German prospective multicentre registry "MYKKE".
    Int J Cardiol. 2022;357:95-104.
    >> Share

  243. JOURY A, Ventura H, Krim SR
    Biomarkers in heart failure: Relevance in the clinical practice.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00935.
    >> Share

  244. KIM CH, Hwang IC, Choi HM, Ahn CH, et al
    Differential cardiovascular and renal benefits of SGLT2 inhibitors and GLP1 receptor agonists in patients with type 2 diabetes mellitus.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00927.
    >> Share

  245. DE LANGE I, Petersen TB, de Bakker M, Akkerhuis KM, et al
    Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study).
    Int J Cardiol. 2022 Jun 14. pii: S0167-5273(22)00919.
    >> Share

  246. SHANG L, Sun H, Tang B, Hou Y, et al
    Metabolic disorders as growing risk factors and comorbidities in heart failure.
    Int J Cardiol. 2022 Jun 2. pii: S0167-5273(22)00822.
    >> Share

  247. IKEDA S, Shinohara K, Enzan N, Matsushima S, et al
    Serial measurement of B-type natriuretic peptide and future cardiovascular events in patients with type 2 diabetes mellitus without known cardiovascular disease.
    Int J Cardiol. 2022;356:98-104.
    >> Share

  248. SABATINO J, Di Salvo G
    The new pandemic: ACHD HF.
    Int J Cardiol. 2022;356:51-52.
    >> Share

    May 2022
  249. LEE SY, Jung MH
    Sex-related differences among young adults with heart failure: Does sex matter?
    Int J Cardiol. 2022 May 31. pii: S0167-5273(22)00808.
    >> Share

  250. HE S, Zhu H, Zhang J, Wu X, et al
    Proteomic analysis of epicardial adipose tissue from heart disease patients with concomitant heart failure with preserved ejection fraction.
    Int J Cardiol. 2022 May 31. pii: S0167-5273(22)00814.
    >> Share

  251. BAUMHOVE L, Tromp J, Figarska S, van Essen BJ, et al
    Heart failure with normal LVEF in BIOSTAT-CHF.
    Int J Cardiol. 2022 May 29. pii: S0167-5273(22)00765.
    >> Share

  252. RIBEIRO GDS, Deresz LF, Salvioni E, Hansen D, et al
    Sensitivity and specificity of different exercise oscillatory ventilation definitions to predict 2-year major adverse cardiovascular outcomes in chronic heart failure patients.
    Int J Cardiol. 2022 May 25. pii: S0167-5273(22)00753.
    >> Share

  253. LIMD Z, LiMD S
    CA125 a cause or an effect in heart failure?
    Int J Cardiol. 2022 May 23. pii: S0167-5273(22)00760.
    >> Share

  254. MOHAMMED SA
    Editorial: Left, but not right, ventricular status determines heart failure in adults with Ebstein anomaly- a case-control study based on magnetic resonance.
    Int J Cardiol. 2022 May 19. pii: S0167-5273(22)00749.
    >> Share

  255. STASSEN J, Khidir M, Galloo X, Hirasawa K, et al
    Prognostic implications of staging cardiac remodeling in patients undergoing cardiac resynchronization therapy.
    Int J Cardiol. 2022;355:65-71.
    >> Share

  256. IWATSU K, Ikeda T, Matsumura K, Ashikawa H, et al
    Gap in the prognostic impact of short physical performance battery among phenotypes of heart failure.
    Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00656.
    >> Share

  257. ANGUITA E, Chaparro A, Candel FJ, Ramos-Acosta C, et al
    Biomarkers of stable and decompensated phases of heart failure with preserved ejection fraction.
    Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00655.
    >> Share

    April 2022
  258. FRIGELLI M, Sturla F, Milani V, Ramputi L, et al
    Prognostic value of left atrial strain quantification from 2D ultrasound imaging in post-ischemic heart failure patients: evidence from the REMODEL-HF study.
    Int J Cardiol. 2022 Apr 30. pii: S0167-5273(22)00633.
    >> Share

  259. BASIC C, Rosengren A, Dahlstrom U, Edner M, et al
    Sex-related differences among young adults with heart failure in Sweden.
    Int J Cardiol. 2022 Apr 28. pii: S0167-5273(22)00635.
    >> Share

  260. CIARDULLO S, Cannistraci R, Mazzetti S, Mortara A, et al
    Twenty-year trends in heart failure among U.S. adults, 1999-2018: The growing impact of obesity and diabetes.
    Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00578.
    >> Share

  261. YU X
    Heart failure with improved ejection fraction: The current and future in Asian populations.
    Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00579.
    >> Share

  262. CIEPLUCHA A, Trojnarska O, Rajewska-Tabor J, Bartczak-Rutkowska A, et al
    Left, but not right, ventricular status determines heart failure in adults with Ebstein anomaly - A case-control study based on magnetic resonance.
    Int J Cardiol. 2022 Apr 25. pii: S0167-5273(22)00585.
    >> Share

  263. LI L, Zhang Z, Xiong Y, Hu Z, et al
    Prediction of hospital mortality in mechanically ventilated patients with congestive heart failure using machine learning approaches.
    Int J Cardiol. 2022 Apr 25. pii: S0167-5273(22)00581.
    >> Share

  264. BERGONTI M, Spera F, Tijskens M, Bonomi A, et al
    A new prediction model for left ventricular systolic function recovery after catheter ablation of atrial fibrillation in patients with heart failure.
    Int J Cardiol. 2022 Apr 17. pii: S0167-5273(22)00554.
    >> Share

  265. CASTIGLIONE V, Vergaro G, Emdin M
    Targeting precipitants to prevent heart failure hospitalization. Does season matter?
    Int J Cardiol. 2022 Apr 17. pii: S0167-5273(22)00561.
    >> Share

  266. RIZZO M, Cianflone D, Maranta F
    Treatment of diabetes and heart failure: Facts and hopes.
    Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00549.
    >> Share

  267. YALCIN YC, Veenis JF, Brugts JJ, Antonides CFJ, et al
    Rate of thromboembolic and bleeding events in patients undergoing concomitant aortic valve surgery with left ventricular assist device implantation.
    Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00555.
    >> Share

  268. ELBADAWI A, Tan BE, Assaf Y, Megaly M, et al
    Digital health intervention in patients with recent hospitalization for acute heart failure: A systematic review and meta-analysis of randomized trials.
    Int J Cardiol. 2022 Apr 15. pii: S0167-5273(22)00553.
    >> Share

  269. SHOJI S, Kohsaka S, Shiraishi Y, Kohno T, et al
    Conventional medical therapy in heart failure patients eligible for the PARADIGM-HF, DAPA-HF, and SHIFT trials.
    Int J Cardiol. 2022 Apr 11. pii: S0167-5273(22)00500.
    >> Share

  270. MAHABADI AA, Anapliotis V, Dykun I, Hendricks S, et al
    Epicardial fat and incident heart failure with preserved ejection fraction in patients with coronary artery disease.
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00489.
    >> Share

  271. ROSENTHAL LL, Ulrich SM, Zimmerling L, Brenner P, et al
    Pediatric heart transplantation in infants and small children under 3years of age: Single center experience - "Early and long-term results".
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00482.
    >> Share

  272. FERREIRA JP, Shah AM, Claggett BL, Pitt B, et al
    Cardiac structure and function and quality of life associations in HFpEF: An analysis from TOPCAT-Americas.
    Int J Cardiol. 2022;352:78-83.
    >> Share

    March 2022
  273. SENGUPTA SP, Okwose NC, MacGowan GA, Jakovljevic DG, et al
    Peak atrio-ventricular mechanics predicts exercise tolerance in heart failure patients.
    Int J Cardiol. 2022 Mar 31. pii: S0167-5273(22)00442.
    >> Share

  274. SU K, Li M, Wang L, Tian S, et al
    Clinical characteristics, predictors, and outcomes of heart failure with improved ejection fraction.
    Int J Cardiol. 2022 Mar 23. pii: S0167-5273(22)00405.
    >> Share

  275. SATO T, Kobayashi Y, Nagai T, Nakatani T, et al
    Long-term preservation of functional capacity and quality of life in advanced heart failure patients with bridge to transplant therapy: A report from Japanese nationwide multicenter registry.
    Int J Cardiol. 2022 Mar 22. pii: S0167-5273(22)00403.
    >> Share

  276. ZHANG Y
    Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
    Int J Cardiol. 2022 Mar 18. pii: S0167-5273(22)00389.
    >> Share

  277. ESPERSEN C, Modin D, Platz E, Jensen GB, et al
    Global and regional wall motion abnormalities and incident heart failure in the general population.
    Int J Cardiol. 2022 Mar 15. pii: S0167-5273(22)00386.
    >> Share

  278. AIMO A, Lupon J, Bayes-Genis A, Emdin M, et al
    Urinary NGAL in acute heart failure revisited: the game is not over yet.
    Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00382.
    >> Share

  279. MINISTRINI S
    Could serum carboxyterminal telopeptide of collagen type I (CITP) have a role in the early diagnosis of heart failure with preserved ejection fraction (HFpEF)?
    Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00383.
    >> Share

  280. JAYAGOPAL PB, Sastry SL, Nanjappa V, Abdullakutty J, et al
    Clinical characteristics and 30-day outcomes in patients with acute decompensated heart failure: Results from Indian College of Cardiology National Heart Failure Registry (ICCNHFR).
    Int J Cardiol. 2022 Mar 13. pii: S0167-5273(22)00381.
    >> Share

  281. BRIDA M, Lovric D, Griselli M, Gil FR, et al
    Heart failure in adults with congenital heart disease.
    Int J Cardiol. 2022 Mar 10. pii: S0167-5273(22)00337.
    >> Share

  282. BILLINGSLEY HE, Canada JM, Dixon DL, Kirkman DL, et al
    Midpoint of energy intake, non-fasting time and cardiorespiratory fitness in heart failure with preserved ejection fraction and obesity.
    Int J Cardiol. 2022 Mar 8. pii: S0167-5273(22)00330.
    >> Share

    February 2022
  283. HORIUCHI Y, Wettersten N, van Veldhuisen DJ, Mueller C, et al
    Decongestion, kidney injury and prognosis in patients with acute heart failure.
    Int J Cardiol. 2022 Feb 21. pii: S0167-5273(22)00261.
    >> Share

  284. CHIANG B, Chew DP, De Pasquale CG
    Outcome trial data on sodium glucose cotransporter-2 inhibitors: Putting clinical benefits and risks in perspective.
    Int J Cardiol. 2022;349:96-98.
    >> Share

  285. TINI G, Cuomo A, Battistoni A, Sarocchi M, et al
    Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice.
    Int J Cardiol. 2022;349:134-137.
    >> Share

  286. ROJAS LZ, Gomez-Ochoa SA, Echeverria LE, Bautista-Nino PK, et al
    Circulating DHEA-S levels and major cardiovascular outcomes in chronic Chagas cardiomyopathy: A prospective cohort study.
    Int J Cardiol. 2022;349:90-95.
    >> Share

  287. MANTOVANI A, Bonapace S, Dugo C, Beatrice G, et al
    Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
    Int J Cardiol. 2022 Feb 12. pii: S0167-5273(22)00248.
    >> Share

  288. DURAN A, De Anda-Duran I, Ventura HO
    The era of heart failure risk prediction models, is it time to test their utility?
    Int J Cardiol. 2022 Feb 9. pii: S0167-5273(22)00218.
    >> Share

  289. CHARANSONNEY OL
    SGLT-2 inhibitors in frail patients with heart failure.
    Int J Cardiol. 2022 Feb 5. pii: S0167-5273(22)00193.
    >> Share

  290. GIRERD N
    The growing importance of heart failure in myocardial infarction.
    Int J Cardiol. 2022 Feb 5. pii: S0167-5273(22)00194.
    >> Share

  291. SALA A, Lorusso R, Alfieri O
    Isolated tricuspid regurgitation: A plea for early correction.
    Int J Cardiol. 2022 Feb 4. pii: S0167-5273(22)00195.
    >> Share

  292. TRAMBAIOLO P, Figliuzzi I, Salvati M, Bertini P, et al
    Ventriculo-arterial coupling in the intensive cardiac care unit: A non-invasive prognostic parameter.
    Int J Cardiol. 2022;348:85-89.
    >> Share

  293. AHMED S, Ahmed A, Radegran G
    The Authors' Reply to the Letter "Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis".
    Int J Cardiol. 2022;348:108.
    >> Share

    January 2022
  294. ROVAI S, Contini M, Sciomer S, Vignati C, et al
    The double anaerobic threshold in heart failure.
    Int J Cardiol. 2022 Jan 25. pii: S0167-5273(22)00136.
    >> Share

  295. DONAL E, L'official G, Kosmala W
    New guidelines for managing chronic heart failure patients and new needs in echocardiography.
    Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00125.
    >> Share

  296. SCRUTINIO D, Guida P, Passantino A, Scalvini S, et al
    Association of improvement in functional capacity after rehabilitation with long-term survival in heart failure.
    Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00129.
    >> Share

  297. CHANG GM, Chen JY, Kuo WY, Tung YC, et al
    Associations of continuity and coordination of care with outcomes and costs after discharge among patients with heart failure: A nationwide population-based study.
    Int J Cardiol. 2022 Jan 19. pii: S0167-5273(22)00118.
    >> Share

  298. ZHENG H, Liang J, Chen X, Chen X, et al
    Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis.
    Int J Cardiol. 2022;347:64-65.
    >> Share

  299. CARLUCCIO E, Dini FL, Bitto R, Ciccarelli M, et al
    Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study.
    Int J Cardiol. 2022 Jan 5. pii: S0167-5273(22)00004.
    >> Share

  300. GIANNONI A, Sciarrone P
    Prognostic impact of diabetes in heart failure: looking back to move forward.
    Int J Cardiol. 2022 Jan 4. pii: S0167-5273(22)00005.
    >> Share

    December 2021
  301. DRISCOLL A, Romanuick H, Dinh D, Amerena J, et al
    Clinical risk prediction model for 30-day all-cause re-hospitalisation or mortality in patients hospitalised with heart failure.
    Int J Cardiol. 2021 Dec 31. pii: S0167-5273(21)02053.
    >> Share

  302. GIACCARI A, Pontremoli R, Filardi PP
    SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice.
    Int J Cardiol. 2021 Dec 31. pii: S0167-5273(21)02054.
    >> Share

  303. RIND IA, Cannata A, McDonaugh B, Cassimon B, et al
    Patients hospitalised with heart failure across different waves of the COVID-19 pandemic show consistent clinical characteristics and outcomes.
    Int J Cardiol. 2021 Dec 29. pii: S0167-5273(21)02045.
    >> Share

  304. DE LUCA L, Cicala SD, D'Errigo P, Cerza F, et al
    Impact of age, gender and heart failure on mortality trends after acute myocardial infarction in Italy.
    Int J Cardiol. 2021 Dec 16. pii: S0167-5273(21)02015.
    >> Share

  305. BHATIA HS, Nishimura M, Martinez A, Vanam S, et al
    Systolic dysfunction in patients with methamphetamine use and heart failure with preserved ejection fraction.
    Int J Cardiol. 2021 Dec 15. pii: S0167-5273(21)02016.
    >> Share

  306. ANABA U, Ishola A, Alabre A, Bui A, et al
    Diversity in modern heart failure trials: Where are we, and where are we going.
    Int J Cardiol. 2021 Dec 14. pii: S0167-5273(21)02010.
    >> Share

  307. BALBI C
    Editorial: Transverse aortic constriction-induced heart failure leads to increased levels of circulating microparticles.
    Int J Cardiol. 2021 Dec 13. pii: S0167-5273(21)01995.
    >> Share

  308. GUAZZI M, Bursi F, Rusconi F
    Lung Biomarkers: a new route for distinguishing pulmonary hypertension due to HFpEF from pulmonary arterial hypertension.
    Int J Cardiol. 2021 Dec 13. pii: S0167-5273(21)01982.
    >> Share

  309. YANDRAPALLI S, Malik AH, Namrata F, Pemmasani G, et al
    Influence of diabetes mellitus interactions with cardiovascular risk factors on post-myocardial infarction heart failure hospitalizations.
    Int J Cardiol. 2021 Dec 2. pii: S0167-5273(21)01976.
    >> Share

  310. SARDU C, Amarelli C
    Continuous flow left ventricular assist devices and cardiac resynchronization: Friends or foe?
    Int J Cardiol. 2021;344:138-139.
    >> Share

  311. LIANG Y, Ding R, Wang J, Gong X, et al
    Prediction of response after cardiac resynchronization therapy with machine learning.
    Int J Cardiol. 2021;344:120-126.
    >> Share

    November 2021
  312. KRIM SR
    Use of plasma renin and aldosterone profiles for prognostication in acute heart failure: A step forward but not ready for prime time.
    Int J Cardiol. 2021 Nov 30. pii: S0167-5273(21)01952.
    >> Share

  313. OSUNDOLIRE S, Naqvi S, Nunes AP, Lapane KL, et al
    Heart failure among US nursing home residents with diabetes mellitus.
    Int J Cardiol. 2021 Nov 23. pii: S0167-5273(21)01777.
    >> Share

  314. KITAI T
    Early intravenous vasodilator therapy in acute decompensated heart failure: Is the time-to-treat concept still applicable in a pre-hospital setting?
    Int J Cardiol. 2021 Nov 20. pii: S0167-5273(21)01859.
    >> Share

  315. REA F, Iorio A, Barbati G, Bessi R, et al
    Patient adherence to drug treatment in a community based-sample of patients with chronic heart failure.
    Int J Cardiol. 2021 Nov 18. pii: S0167-5273(21)01788.
    >> Share

  316. FUDIM M, Devaraj S, Chukwurah M, Ajam T, et al
    Prognosis for patients with heart failure and reduced ejection fraction with and without diabetes: A 7 year nationwide veteran administration analysis.
    Int J Cardiol. 2021 Nov 17. pii: S0167-5273(21)01849.
    >> Share

  317. LAMMERS AE, Sprenger KS, Diller GP, Miera O, et al
    Ventricular assist devices in paediatric cardiomyopathy and congenital heart disease: An analysis of the German National Register for Congenital Heart Defects.
    Int J Cardiol. 2021;343:37-44.
    >> Share

  318. GORI M, Marini M, De Maria R, Gonzini L, et al
    Age-related changes in clinical characteristics and outcomes of chronic heart failure outpatients in a cardiology setting. A report from the Italian Network on Heart Failure.
    Int J Cardiol. 2021 Nov 15. pii: S0167-5273(21)01783.
    >> Share

  319. MO M, Xia N, Liao Y
    Letter on "Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: A meta-analysis of randomized controlled trials".
    Int J Cardiol. 2021 Nov 13. pii: S0167-5273(21)01839.
    >> Share

  320. TEMPORELLI PL, Arbelo E, Laroche C, Blomstrom-Lundqvist C, et al
    Atrial fibrillation ablation in heart failure: Findings from the ESC-EHRA EORP Atrial Fibrillation Ablation long-term (AFA LT) registry.
    Int J Cardiol. 2021 Nov 11. pii: S0167-5273(21)01779.
    >> Share

  321. PFEIFER P, Zietzer A, Holscher M, Jehle J, et al
    Transverse aortic constriction-induced heart failure leads to increased levels of circulating microparticles.
    Int J Cardiol. 2021 Nov 10. pii: S0167-5273(21)01772.
    >> Share

  322. UDANI K, Chris-Olaiya A, Ohadugha C, Malik A, et al
    Cardiovascular manifestations in hospitalized patients with hemochromatosis in the United States.
    Int J Cardiol. 2021;342:117-124.
    >> Share

  323. FASTNER C, Yuecel G, Rudic B, Schmiel G, et al
    Cardiac Contractility Modulation in Patients with Ischemic versus Non-ischemic Cardiomyopathy: Results from the MAINTAINED Observational Study.
    Int J Cardiol. 2021;342:49-55.
    >> Share

    October 2021
  324. BIEGUS J, Nawrocka-Millward S, Zymlinski R, Fudim M, et al
    Distinct renin/aldosterone activity profiles correlate with renal function, natriuretic response, decongestive ability and prognosis in acute heart failure.
    Int J Cardiol. 2021 Oct 30. pii: S0167-5273(21)01703.
    >> Share

  325. AHMED S, Ahmed A, Radegran G
    Plasma tumour and metabolism related biomarkers AMBP, LPL and Glyoxalase I differentiate heart failure with preserved ejection fraction with pulmonary hypertension from pulmonary arterial hypertension.
    Int J Cardiol. 2021 Oct 25. pii: S0167-5273(21)01690.
    >> Share

  326. HE Z, Yang L, Nie Y, Wang Y, et al
    Effects of SGLT-2 inhibitors on health-related quality of life and exercise capacity in heart failure patients with reduced ejection fraction: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Oct 12. pii: S0167-5273(21)01562.
    >> Share

  327. YOUN JC, Baek SH
    Heart failure risk in younger adults needing more attention.
    Int J Cardiol. 2021 Oct 8. pii: S0167-5273(21)01560.
    >> Share

  328. ARENJA N, Mueller C, Tomilovskaya E, Koryak Y, et al
    Real-world experience of feasibility and efficacy of electrical muscle stimulation in elderly patients with acute heart failure: A randomized controlled study.
    Int J Cardiol. 2021 Oct 7. pii: S0167-5273(21)01504.
    >> Share

  329. DARDEN D, Ammirati E, Brambatti M, Lin A, et al
    Cardiovascular implantable electronic device therapy in patients with left ventricular assist devices: insights from TRAViATA.
    Int J Cardiol. 2021;340:26-33.
    >> Share

    September 2021
  330. MIRO O, Llorens P, Freund Y, Davison B, et al
    Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure: Insights from the EAHFE Spanish registry.
    Int J Cardiol. 2021 Sep 17. pii: S0167-5273(21)01470.
    >> Share

  331. DLOUHA D, Ivak P, Netuka I, Novakova S, et al
    The effect of long-term left ventricular assist device support on flow-sensitive plasma microRNA levels.
    Int J Cardiol. 2021;339:138-143.
    >> Share

  332. WEBER C, Hung J, Hickling S, Li I, et al
    Changing age-specific trends in incidence, comorbidities and mortality of hospitalised heart failure in Western Australia between 2001 and 2016.
    Int J Cardiol. 2021 Sep 11. pii: S0167-5273(21)01376.
    >> Share

  333. KAPELIOS CJ, Canepa M, Benson L, Hage C, et al
    Non-cardiology vs. cardiology care of patients with heart failure and reduced ejection fraction is associated with lower use of guideline-based care and higher mortality: Observations from The Swedish Heart Failure Registry.
    Int J Cardiol. 2021 Sep 10. pii: S0167-5273(21)01334.
    >> Share

  334. GUIMARAES GV, Ribeiro F, Castro RE, Roque JM, et al
    Effects of the exercise training on skeletal muscle oxygen consumption in heart failure patients with reduced ejection fraction.
    Int J Cardiol. 2021 Sep 7. pii: S0167-5273(21)01318.
    >> Share

  335. AMARELLI C, Limongelli G
    Cardiac amyloidosis: Watching the tip of the iceberg emerging from the "heart of the sea".
    Int J Cardiol. 2021;338:226-228.
    >> Share

  336. BODE N, Hochadel M, Andresen D, Zahn R, et al
    Cardiac glycosides are not associated with increased mortality or hospitalization rates in ICD and CRT-ICD patients after adjustment for baseline-characteristics at one-year follow-up: Results from the German DEVICE registry.
    Int J Cardiol. 2021;338:109-114.
    >> Share

    August 2021
  337. MONZO L, Ferrari I, Cicogna F, Tota C, et al
    Sodium-glucose co-transporter-2 inhibitors eligibility in patients with heart failure with reduced ejection fraction.
    Int J Cardiol. 2021 Aug 26. pii: S0167-5273(21)01301.
    >> Share

  338. KANEKO H, Itoh H, Kamiya K, Morita K, et al
    Acute-phase initiation of cardiac rehabilitation and clinical outcomes in hospitalized patients for acute heart failure.
    Int J Cardiol. 2021 Aug 26. pii: S0167-5273(21)01307.
    >> Share

  339. NAKAO K, Yasuda S, Noguchi T, Sumita Y, et al
    Association of hospital performance measures with readmissions for patients with heart failure: A report from JROAD-DPC study.
    Int J Cardiol. 2021 Aug 19. pii: S0167-5273(21)01229.
    >> Share

  340. VINTER N, Frost L, Benjamin EJ
    Heart failure and atrial fibrillation - does heart failure subtype matter?
    Int J Cardiol. 2021 Aug 6. pii: S0167-5273(21)01216.
    >> Share

  341. TADA A, Nagai T, Omote K, Iwano H, et al
    Performance of the H2FPEF and the HFA-PEFF scores for the diagnosis of heart failure with preserved ejection fraction in Japanese patients: A report from the Japanese multicenter registry.
    Int J Cardiol. 2021 Aug 5. pii: S0167-5273(21)01211.
    >> Share

    July 2021
  342. MATETIC A, Mohamed M, Miller RJH, Kolman L, et al
    Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions.
    Int J Cardiol. 2021 Jul 29. pii: S0167-5273(21)01197.
    >> Share

  343. ABBOUD A, Gaggin HK
    Heart failure and frailty: Expanding the gender paradox.
    Int J Cardiol. 2021 Jul 24. pii: S0167-5273(21)01190.
    >> Share

  344. ZHOU Y, Chen S, Rao Z, Yang D, et al
    Prediction of 1-year mortality after heart transplantation using machine learning approaches: A single-center study from China.
    Int J Cardiol. 2021 Jul 13. pii: S0167-5273(21)01169.
    >> Share

  345. NJI MAM, Solomon SD, Chen LY, Shah AM, et al
    Association of heart failure subtypes and atrial fibrillation: Data from the Atherosclerosis Risk in Communities (ARIC) study.
    Int J Cardiol. 2021 Jul 8. pii: S0167-5273(21)01100.
    >> Share

  346. VALERIANOVA A, Malik J, Janeckova J, Kovarova L, et al
    Reduction of arteriovenous access blood flow leads to biventricular unloading in haemodialysis patients.
    Int J Cardiol. 2021;334:148-153.
    >> Share

    June 2021
  347. DE LA ESPRIELLA R, Minana G, Santas E, Nunez G, et al
    Effects of empagliflozin on CA125 trajectory in patients with chronic congestive heart failure.
    Int J Cardiol. 2021 Jun 30. pii: S0167-5273(21)01084.
    >> Share

  348. ISHIWATA S, Matsue Y, Nakamura Y, Dotare T, et al
    Clinical and prognostic values of urinary alpha1-microglobulin as a tubular marker in acute heart failure.
    Int J Cardiol. 2021 Jun 26. pii: S0167-5273(21)01079.
    >> Share

  349. DURAN A, daSilva-deAbreu A, Joury A, Ventura HO, et al
    FGF23 predicts outcomes in heart failure but questions remain unanswered.
    Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01034.
    >> Share

  350. ILONZE OJ, Guglin M
    Vericiguat, organic nitrates, and heart failure in African Americans.
    Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01031.
    >> Share

  351. DOLDI PM, Buech J, Orban M, Samson-Himmelstjerna P, et al
    Transcatheter mitral valve repair may increase eligibility for heart transplant listing in patients with end-stage heart failure and severe secondary mitral regurgitation.
    Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01029.
    >> Share

  352. KEULARDS DCJ, Bouwmeester S, de Vos AMJ, Dekker LRC, et al
    High microvascular resistance and reduced left atrial strain in patients with coronary microvascular dysfunction: The micro-strain study.
    Int J Cardiol. 2021;333:21-28.
    >> Share

  353. DASILVA-DEABREU A, Lavie CJ, Mehra MR
    Bridging the palliative care chasm in advanced heart failure.
    Int J Cardiol. 2021 Jun 15. pii: S0167-5273(21)00969.
    >> Share

  354. WANG M, Luo B
    Levosimendan is safe to patients with advanced heart failure and hypotension.
    Int J Cardiol. 2021 Jun 9. pii: S0167-5273(21)00914.
    >> Share

  355. EMOTO T, Hayashi T, Tabata T, Yamashita T, et al
    Metagenomic analysis of gut microbiota reveals its role in trimethylamine metabolism in heart failure.
    Int J Cardiol. 2021 Jun 5. pii: S0167-5273(21)00962.
    >> Share

  356. LIU L, Lima JAC, Post WS, Szklo M, et al
    Associations of time-varying obesity and metabolic syndrome with risk of incident heart failure and its subtypes: Findings from the Multi-Ethnic Study of Atherosclerosis.
    Int J Cardiol. 2021 Jun 2. pii: S0167-5273(21)00908.
    >> Share

  357. POTRATZ M, Fox H, Rudolph V, Faber L, et al
    Respiratory dyssynchrony is a predictor of prognosis in patients with hypertrophic non-obstructive cardiomyopathy.
    Int J Cardiol. 2021;332:105-112.
    >> Share

    May 2021
  358. AIMO A
    Longitudinal changes in cardiac biomarkers and outcome in heart failure: Sex-related differences.
    Int J Cardiol. 2021 May 18. pii: S0167-5273(21)00839.
    >> Share

  359. VERGARO G, Aimo A, Taurino E, Del Franco A, et al
    Discharge FGF23 levels predicts one year outcome in patients admitted with acute heart failure.
    Int J Cardiol. 2021 May 18. pii: S0167-5273(21)00840.
    >> Share

  360. SAMUEL TJ, Wei J, Sharif B, Tamarappoo BK, et al
    Diastolic dysfunction in women with ischemia and no obstructive coronary artery disease: Mechanistic insight from magnetic resonance imaging.
    Int J Cardiol. 2021;331:1-7.
    >> Share

  361. GALLI E, Smiseth OA MD, PhD, Aalen JM, Larsen CK, et al
    Prognostic utility of the assessment of diastolic function in patients undergoing cardiac resynchronization therapy.
    Int J Cardiol. 2021;331:144-151.
    >> Share

  362. MACGOWAN GA, Woods A, Robinson-Smith N, Tovey S, et al
    Using existing technology better: Improving outcomes with the HeartWare left ventricular assist device.
    Int J Cardiol. 2021;331:35-39.
    >> Share

  363. SHARIATI F, Baldawi H, Bob-Manuel T
    Editorial: Premature death from heart failure among Aboriginal peoples in the Hunter New England region of new South Wales.
    Int J Cardiol. 2021 May 14. pii: S0167-5273(21)00838.
    >> Share

  364. KAMIYA K, Adachi T, Iwatsu K, Kamisaka K, et al
    Association between a pre-admission limitation in walking ability and post-discharge adverse outcomes among hospitalized patients with heart failure: Report from a multicenter prospective cohort study.
    Int J Cardiol. 2021 May 12. pii: S0167-5273(21)00832.
    >> Share

  365. SACCO A, Morici N, Villanova L, Viola G, et al
    Withdrawal of active treatments in terminally ill heart failure patients.
    Int J Cardiol. 2021 May 5. pii: S0167-5273(21)00815.
    >> Share

  366. KLEIN HU
    Cardiac resynchronization therapy with- or without defibrillator. Estimating the risk of arrhythmic death or assessing the likelihood of non-arrhythmic mortality?
    Int J Cardiol. 2021;330:82-83.
    >> Share

    April 2021
  367. SCHREUDER MM, Schuurman A, Akkerhuis KM, Constantinescu AA, et al
    Sex-specific temporal evolution of circulating biomarkers in patients with chronic heart failure with reduced ejection fraction.
    Int J Cardiol. 2021 Apr 30. pii: S0167-5273(21)00804.
    >> Share

  368. GORI M, Claggett B, Senni M, Shah AM, et al
    Combining diastolic dysfunction and natriuretic peptides to risk stratify patients with heart failure with reduced ejection fraction.
    Int J Cardiol. 2021 Apr 19. pii: S0167-5273(21)00664.
    >> Share

  369. AIMO A, Manetti S, Emdin M
    How much is it to mend a broken heart? Results from the US Nationwide Readmission Database.
    Int J Cardiol. 2021;329:150-151.
    >> Share

  370. MCGEE M, Sugito S, Al-Omary MS, Hartnett D, et al
    Heart failure outcomes in Aboriginal and Torres Strait Islander peoples in the Hunter New England region of New South Wales.
    Int J Cardiol. 2021 Apr 8. pii: S0167-5273(21)00637.
    >> Share

  371. LI X, Zhang Q, Zhu L, Wang G, et al
    Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2021 Apr 7. pii: S0167-5273(21)00636.
    >> Share

  372. CAO M, Stolen CM, Ahmed R, Schloss EJ, et al
    Small decreases in biventricular pacing percentages are associated with multiple metrics of worsening heart failure as measured from a cardiac resynchronization therapy defibrillator.
    Int J Cardiol. 2021 Apr 1. pii: S0167-5273(21)00632.
    >> Share

  373. QAMRUDDIN S, Ventura HO
    Serial echocardiographic parameters to evaluate prognosis in patients with HFrEF - is it worth the second test?
    Int J Cardiol. 2021;328:141-142.
    >> Share

  374. REINHOLD J, Papadopoulou C, Baral R, Vassiliou VS, et al
    Iron deficiency for prognosis in acute coronary syndrome - A systematic review and meta-analysis.
    Int J Cardiol. 2021;328:46-54.
    >> Share

  375. COHEN ARAZI H, Chirino D, Costabel JP, Pulmari CA, et al
    Leuko-platelet index predicts thrombotic events in patients with acute coronary syndrome.
    Int J Cardiol. 2021;328:29-34.
    >> Share

    March 2021
  376. JACKSON AO, Rahman GA, Long S
    Attenuating senescence and dead cells accumulation as heart failure therapy: Break the communication networks.
    Int J Cardiol. 2021 Mar 29. pii: S0167-5273(21)00565.
    >> Share

  377. SURKOVA E, Dimopoulos K, Li W
    Reply to: "Systolic dysfunction of the subpulmonary left ventricle in the systemic right ventricle: late manifestation or subclinical predictor of heart failure?"
    Int J Cardiol. 2021 Mar 27. pii: S0167-5273(21)00621.
    >> Share

  378. LAINSCAK M, Omersa D, Rosano G, Farkas J, et al
    Pharmacotherapy adherence in patients with heart failure: Easier said than done.
    Int J Cardiol. 2021 Mar 27. pii: S0167-5273(21)00555.
    >> Share

  379. LI Y, Li L, Wang C
    Insulin-like growth factor binding protein 2 might be a novel therapeutic target in the treatment of heart failure.
    Int J Cardiol. 2021 Mar 19. pii: S0167-5273(21)00549.
    >> Share

  380. COHEN S, Liu A, Abrahamowicz M, Brophy JM, et al
    Reply to "Risk prediction models for heart failure admissions in adults with congenital heart disease: Methodological issues".
    Int J Cardiol. 2021 Mar 19. pii: S0167-5273(21)00482.
    >> Share

  381. TANG L, Liu J, Zheng J
    Targeting mitochondrial calcium uniporter in heart failure.
    Int J Cardiol. 2021 Mar 16. pii: S0167-5273(21)00485.
    >> Share

  382. AL-WAKEEL-MARQUARD N, Seidel F, Herbst C, Kuhnisch J, et al
    Diffuse myocardial fibrosis by T1 mapping is associated with heart failure in pediatric primary dilated cardiomyopathy.
    Int J Cardiol. 2021 Mar 15. pii: S0167-5273(21)00480.
    >> Share

  383. GHIO S, Carluccio E, Scardovi AB, Dini FL, et al
    Prognostic relevance of Doppler echocardiographic re-assessment in HFrEF patients.
    Int J Cardiol. 2021;327:111-116.
    >> Share

  384. KOCHAV SM, Raita Y, Fifer MA, Takayama H, et al
    Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning.
    Int J Cardiol. 2021;327:117-124.
    >> Share

  385. CARLUCCIO E, Pugliese NR, Biagioli P, Zuchi C, et al
    Global longitudinal strain in heart failure with reduced ejection fraction: Prognostic relevance across disease severity as assessed by automated cluster analysis.
    Int J Cardiol. 2021 Mar 10. pii: S0167-5273(21)00383.
    >> Share

  386. HIGUCHI S, Shibata S, Hasegawa H, Matsuda T, et al
    Reply to the letter to the editor: "Clinical impact of red blood cell transfusion on adverse clinical events in acute heart failure patients with anemia".
    Int J Cardiol. 2021 Mar 4. pii: S0167-5273(21)00458.
    >> Share

  387. STIENEN S, Ferreira JP, Bar C, Thum T, et al
    Serum microRNAs and antifibrotic response to eplerenone in acute myocardial infarction complicated by systolic dysfunction.
    Int J Cardiol. 2021 Mar 4. pii: S0167-5273(21)00399.
    >> Share

  388. BARISON A, Aimo A, Emdin M
    Cocaine and methamphetamine use and hospitalization for acute heart failure: Epidemiological evidence from a nationwide dataset.
    Int J Cardiol. 2021 Mar 3. pii: S0167-5273(21)00387.
    >> Share

  389. OLSEN FJ, Biering-Sorensen T
    Right atrial strain: Tapping into a new reservoir of hemodynamic information.
    Int J Cardiol. 2021;326:226-228.
    >> Share

  390. YEUNG DF, Jiang R, Behnami D, Jue J, et al
    Impact of the updated diastolic function guidelines in the real world.
    Int J Cardiol. 2021;326:124-130.
    >> Share

  391. SAVIRA F, Kompa AR, Edgley AJ, Jucker BM, et al
    RE: Blockade of apoptosis signal-regulating kinase 1 ameliorates cardiac dysfunction in cardiorenal syndrome via enhancing angiogenesis.
    Int J Cardiol. 2021;326:156.
    >> Share

    February 2021
  392. DAVIS MR, Lee CS, Corcoran A, Gupta N, et al
    Gender differences in the prevalence of frailty in heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Feb 28. pii: S0167-5273(21)00371.
    >> Share

  393. NITTA G, Inaba O, Kato S, Kono T, et al
    Catheter ablation for atrial fibrillation in patients with congestive heart failure.
    Int J Cardiol. 2021 Feb 26. pii: S0167-5273(21)00369.
    >> Share

  394. PAOLILLO S, Salvioni E, Perrone Filardi P, Bonomi A, et al
    Corrigendum to "Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database" [Int J Cardiol. 2020 Oct 15; 317: 103-110. PMID: 32360652].
    Int J Cardiol. 2021 Feb 25. pii: S0167-5273(21)00354.
    >> Share

  395. VAN DEN EYNDE J, Santens B, Van De Bruaene A, Budts W, et al
    Systolic dysfunction of the subpulmonary left ventricle in the systemic right ventricle: Late manifestation or subclinical predictor of heart failure?
    Int J Cardiol. 2021 Feb 25. pii: S0167-5273(21)00368.
    >> Share

  396. RAJDEV K, Lahan S, Wichman T
    Role of pulmonary arterial capacitance in predicting mortality in patients with pulmonary hypertension: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Feb 20. pii: S0167-5273(21)00296.
    >> Share

  397. ELBADAWI A, Dang A, Elgendy IY, Thakker R, et al
    Age-specific trends and outcomes of hospitalizations with acute heart failure in the United States.
    Int J Cardiol. 2021 Feb 17. pii: S0167-5273(21)00284.
    >> Share

  398. HSIAO FC, Lin CP, Tung YC, Chang PC, et al
    Combining sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors in heart failure patients with reduced ejection fraction and diabetes mellitus: A multi-institutional study.
    Int J Cardiol. 2021 Feb 12. pii: S0167-5273(21)00288.
    >> Share

  399. SCALVINI S, Bernocchi P, Villa S, Paganoni AM, et al
    Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: A population-based retrospective study on 100,785 patients.
    Int J Cardiol. 2021 Feb 11. pii: S0167-5273(21)00267.
    >> Share

  400. PASSINO C, Sciarrone P, Vergaro G, Borrelli C, et al
    Sacubitril-valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction.
    Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00263.
    >> Share

  401. WANG X, Li X
    Clinical impact of red blood cell transfusion on adverse clinical events in acute heart failure patients with anemia.
    Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00269.
    >> Share

  402. SAKANE K, Kanzaki Y, Hoshiga M
    Reply to "Clinical Significance of B-type Natriuretic Peptide in Patient with Acute Decompensated Heart Failure".
    Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00272.
    >> Share

  403. LEGENDRE A, Moatemri F, Kovalska O, Balice-Pasquinelli M, et al
    Responses to exercise training in patients with heart failure. Analysis by oxygen transport steps.
    Int J Cardiol. 2021 Feb 8. pii: S0167-5273(21)00255.
    >> Share

  404. PROUDFOOT C, Studer R, Rajput T, Jindal R, et al
    Real-world effectiveness and safety of sacubitril/valsartan in heart failure: A systematic review.
    Int J Cardiol. 2021 Feb 2. pii: S0167-5273(21)00143.
    >> Share

  405. VERONESE G, Ammirati E, Chen C, Klingel K, et al
    Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis.
    Int J Cardiol. 2021;324:131-138.
    >> Share

    January 2021
  406. SHETTY S, Malik AH, Ali A, Yang YC, et al
    Characteristics, trends, outcomes, and costs of stimulant-related acute heart failure hospitalizations in the United States.
    Int J Cardiol. 2021 Jan 31. pii: S0167-5273(21)00142.
    >> Share

  407. NOURAEI H, Rabkin SW
    A new approach to the clinical subclassification of heart failure with preserved ejection fraction.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00134.
    >> Share

  408. THEUNS DAMJ, Schaer BA, Caliskan K, Hoeks SE, et al
    Application of the heart failure meta-score to predict prognosis in patients with cardiac resynchronization defibrillators.
    Int J Cardiol. 2021 Jan 28. pii: S0167-5273(21)00091.
    >> Share

  409. SABOUR S, Ghajari H
    Risk prediction models for heart failure admissions in adults with congenital heart disease: Methodological issues.
    Int J Cardiol. 2021 Jan 25. pii: S0167-5273(21)00083.
    >> Share

  410. CAMELI M, Pastore MC, Mandoli GE
    Left atrial strain: A key element for the evaluation of patients with HFpEF.
    Int J Cardiol. 2021;323:197-198.
    >> Share

  411. SAVIRA F, Edgley AJ, Jucker BM, Willette RN, et al
    RE: Inhibition of apoptosis signal-regulating kinase 1 might be a novel therapeutic target in the treatment of cardiorenal syndrome.
    Int J Cardiol. 2021;323:260.
    >> Share

  412. WEI WY, Lian ZX, Ji Y, Zhang N, et al
    Blockade of apoptosis signal-regulating kinase 1 ameliorates cardiac dysfunction in cardiorenal syndrome via enhancing angiogenesis.
    Int J Cardiol. 2021;323:205.
    >> Share

  413. DANI SS, Ganatra S, Vaduganathan M
    Angioedema with sacubitril/valsartan: Trial-level meta-analysis of over 14,000 patients and real-world evidence to date.
    Int J Cardiol. 2021;323:188-191.
    >> Share

  414. IZUMIDA T, Imamura T
    Clinical significance of B-type natriuretic peptide in patient with acute decompensated heart failure.
    Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34326.
    >> Share

  415. GALLO-BERNAL S, Calixto CA, Molano-Gonzalez N, Moreno MPD, et al
    Impact of a pharmacist-based multidimensional intervention aimed at decreasing the risk of hyperkalemia in heart failure patients: A Latin-American experience.
    Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34329.
    >> Share

  416. KUMAR V, Ryu AJ, Manduca A, Rao C, et al
    Cardiac MRI demonstrates compressibility in healthy myocardium but not in myocardium with reduced ejection fraction.
    Int J Cardiol. 2021;322:278-283.
    >> Share

  417. RYU AJ, Kumar V, Borlaug BA, Manduca A, et al
    Systolic-to-diastolic myocardial volume ratio as a novel imaging marker of cardiomyopathy.
    Int J Cardiol. 2021;322:272-277.
    >> Share

    December 2020
  418. KAWADA T
    Risk of heart failure and prognosis in patients with atrial fibrillation.
    Int J Cardiol. 2020 Dec 31. pii: S0167-5273(20)34316.
    >> Share

  419. IMAMURA T
    Therapeutic strategy for the patients with Takayasu arteritis and heart failure.
    Int J Cardiol. 2020 Dec 31. pii: S0167-5273(20)34318.
    >> Share

  420. MAGGIONI AP
    How to appropriately update practicing clinicians on innovations in heart failure therapy waiting for the new version of the guidelines?
    Int J Cardiol. 2020 Dec 24. pii: S0167-5273(20)34290.
    >> Share

  421. PESTELLI G, Fiorencis A, Trevisan F, Luisi GA, et al
    New measures of right ventricle-pulmonary artery coupling in heart failure: An all-cause mortality echocardiographic study.
    Int J Cardiol. 2020 Dec 22. pii: S0167-5273(20)34305.
    >> Share

  422. AGARWAL A, Mohanan PP, Kondal D, Baldridge A, et al
    Effect of a quality improvement intervention for acute heart failure in South India: An interrupted time series study.
    Int J Cardiol. 2020 Dec 21. pii: S0167-5273(20)34296.
    >> Share

  423. GAU SY
    Confusing heart failure ischemic etiology prevalence trend and the definition of composite events.
    Int J Cardiol. 2020 Dec 14. pii: S0167-5273(20)34276.
    >> Share

  424. KWOK CS, Abramov D, Parwani P, Ghosh RK, et al
    Cost of inpatient heart failure care and 30-day readmissions in the United States.
    Int J Cardiol. 2020 Dec 12. pii: S0167-5273(20)34268.
    >> Share

  425. TAKAHAMA H, Izumi C
    Palliative care for patients with advanced heart failure: When is the optimal timing of advanced care planning?
    Int J Cardiol. 2020 Dec 7. pii: S0167-5273(20)34251.
    >> Share

  426. VOLPE M, Bauersachs J, Bayes-Genis A, Butler J, et al
    Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence.
    Int J Cardiol. 2020 Dec 7. pii: S0167-5273(20)34242.
    >> Share

  427. SAKANE K, Kanzaki Y, Tsuda K, Maeda D, et al
    Disproportionately low BNP levels in patients of acute heart failure with preserved vs. reduced ejection fraction.
    Int J Cardiol. 2020 Dec 3. pii: S0167-5273(20)34235.
    >> Share

  428. CHIONCEL O, Ambrosy AP
    Improving adherence to guideline-directed medical therapies and outcomes in the developing world: A call to end global inequities in heart failure.
    Int J Cardiol. 2020 Dec 2. pii: S0167-5273(20)34230.
    >> Share

  429. PAN J, Wang L, Sun Y
    Inhibition of apoptosis signal-regulating kinase 1 might be a novel therapeutic target in the treatment of cardiorenal syndrome.
    Int J Cardiol. 2020;320:139.
    >> Share

    November 2020
  430. FERNANDEZ-MARTINEZ J, Romero-Correa M, Salamanca-Bautista P, Aramburu-Bodas O, et al
    Prevalence of advanced heart failure and use of palliative care in admitted patients: Findings from the EPICTER study.
    Int J Cardiol. 2020 Nov 7. pii: S0167-5273(20)34076.
    >> Share

  431. WANG Y, Tse G, Roever L, Liu T, et al
    Sacubitril/valsartan in the treatment of cancer therapy-related cardiac dysfunction.
    Int J Cardiol. 2020;318:130.
    >> Share

    October 2020
  432. SCHWARTZ B, Schou M, Gislason GH, Kober L, et al
    Prevalence and incidence of various cancer subtypes in patients with heart failure vs matched controls.
    Int J Cardiol. 2020 Oct 31. pii: S0167-5273(20)34065.
    >> Share

  433. PUGLIESE NR, Rosada J, Masi S
    Train the brain to preserve the heart: the link between education and heart failure.
    Int J Cardiol. 2020 Oct 30. pii: S0167-5273(20)34057.
    >> Share

  434. RAVAL AN, Johnston PV, Duckers HJ, Cook TD, et al
    Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort.
    Int J Cardiol. 2020 Oct 19. pii: S0167-5273(20)33996.
    >> Share

  435. ZHANG Y, Fan P, Zhang H, Ma W, et al
    Clinical characteristics and outcomes of chronic heart failure in adult Takayasu arteritis: A cohort study of 163 patients.
    Int J Cardiol. 2020 Oct 18. pii: S0167-5273(20)33984.
    >> Share

  436. HARIKRISHNAN S, Jeemon P, Ganapathi S, Agarwal A, et al
    Five-year mortality and readmission rates in patients with heart failure in India: Results from the Trivandrum heart failure registry.
    Int J Cardiol. 2020 Oct 10. pii: S0167-5273(20)33921.
    >> Share

  437. LEE SY, Kim HL, Kim MA, Park JJ, et al
    Obesity paradox in Korean male and female patients with heart failure: A report from the Korean heart failure registry.
    Int J Cardiol. 2020 Oct 9. pii: S0167-5273(20)33922.
    >> Share

  438. SHARMA K, Premchand RK, Mittal S, Monteiro R, et al
    Long-term follow-up of patients with heart failure and reduced ejection receiving autonomic regulation therapy in the ANTHEM-HF pilot study.
    Int J Cardiol. 2020 Oct 7. pii: S0167-5273(20)33902.
    >> Share

  439. PANA TA, Mohamed MO, Clark AB, Fahy E, et al
    Revascularisation therapies improve the outcomes of ischemic stroke patients with atrial fibrillation and heart failure.
    Int J Cardiol. 2020 Oct 3. pii: S0167-5273(20)33906.
    >> Share

  440. LIAO LZ, Zhuang XD, Zhang SZ, Liao XX, et al
    Education and heart failure: New insights from the atherosclerosis risk in communities study and mendelian randomization study.
    Int J Cardiol. 2020 Oct 2. pii: S0167-5273(20)33898.
    >> Share

  441. ZHONG P, Yuan M, Kong B, Huang H, et al
    ASK-1, a new target in treating cardiorenal syndrome (CRS).
    Int J Cardiol. 2020;316:208.
    >> Share

  442. SAVIRA F, Kompa AR, Edgley AJ, Jucker BM, et al
    RE: ASK1, a new target in treating cardiorenal syndrome (CRS).
    Int J Cardiol. 2020;316:207.
    >> Share

    September 2020
  443. SHIBATA N, Kondo T, Kazama S, Kimura Y, et al
    Impact of predictive value of Fibrosis-4 index in patients hospitalized for acute heart failure.
    Int J Cardiol. 2020 Sep 29. pii: S0167-5273(20)33837.
    >> Share

  444. SURKOVA E, Segura T, Dimopouosl K, Bispo D, et al
    Systolic dysfunction of the subpulmonary left ventricle is associated with the severity of heart failure in patients with a systemic right ventricle.
    Int J Cardiol. 2020 Sep 25. pii: S0167-5273(20)33832.
    >> Share

  445. AMMIRATI E, Brambatti M, Braun OO, Shah P, et al
    Outcome of patients on heart transplant list treated with a continuous-flow left ventricular assist device: Insights from the TRans-Atlantic registry on VAd and TrAnsplant (TRAViATA).
    Int J Cardiol. 2020 Sep 17. pii: S0167-5273(20)33807.
    >> Share

  446. BRIDA M
    Heart transplantation in adult congenital heart disease: Importance of timely referral.
    Int J Cardiol. 2020 Sep 14. pii: S0167-5273(20)33822.
    >> Share

    August 2020
  447. MERAS P, Riesgo-Gil F, Rybicka J, Barradas-Pires A, et al
    Heart transplantation at a single tertiary adult congenital heart disease centre: Too little, too late?
    Int J Cardiol. 2020 Aug 13. pii: S0167-5273(20)33574.
    >> Share

  448. SANDERSON JE, Fang F
    Cardiac cycle time intervals are back again.
    Int J Cardiol. 2020;312:87-88.
    >> Share

    July 2020
  449. ALKHALIL M, Kearney A, MacElhatton D, Fergie R, et al
    The prognostic role of mid-range ejection fraction in ST-segment elevation myocardial infarction.
    Int J Cardiol. 2020 Jul 15. pii: S0167-5273(20)33449.
    >> Share

    April 2020
  450. LEE EC, McNitt S, Martens J, Bruckel JT, et al
    Long-term milrinone therapy as a bridge to heart transplantation: Safety, efficacy, and predictors of failure.
    Int J Cardiol. 2020 Apr 19. pii: S0167-5273(19)34902.
    >> Share

    March 2020
  451. GAVAZZONI M, Taramasso M, Zuber M, Pozzoli A, et al
    Functional mitral regurgitation and cardiac resynchronization therapy in the "era" of trans-catheter interventions: Is it time to move from a staged strategy to a tailored therapy?
    Int J Cardiol. 2020 Mar 28. pii: S0167-5273(19)35293.
    >> Share

    February 2020
  452. RASHID M, Curzen N, Kinnaird T, Lawson CA, et al
    Baseline risk, timing of invasive strategy and guideline compliance in NSTEMI: Nationwide analysis from MINAP.
    Int J Cardiol. 2020;301:7-13.
    >> Share

  453. LAHUERTA C, Menao S, Gracia-Gutierrez A, Bueno-Juana E, et al
    Diagnosis of genetic amyloidosis through the analysis of transthyretin gene mutation using high-resolution melting.
    Int J Cardiol. 2020;301:220-225.
    >> Share

  454. CAZZOLI I, Gunturiz-Beltran C, Guarguagli S, Alonso-Gonzalez R, et al
    Catheter ablation for patients with end-stage complex congenital heart disease or cardiomyopathy considered for transplantation: Trials and tribulations.
    Int J Cardiol. 2020;301:127-134.
    >> Share

    January 2020
  455. SPEE RF, Niemeijer VM, Schoots T, Tuinenburg A, et al
    High intensity interval training after cardiac resynchronization therapy: An explorative randomized controlled trial.
    Int J Cardiol. 2020;299:169-174.
    >> Share

    December 2019
  456. GRAMEGNA M, Beneduce A, Bertoldi LF, Pagnesi M, et al
    Impella RP support in refractory right ventricular failure complicating acute myocardial infarction with unsuccessful right coronary artery revascularization.
    Int J Cardiol. 2019 Dec 13. pii: S0167-5273(19)35516.
    >> Share

    October 2019
  457. GARCIA R, Boveda S, Defaye P, Sadoul N, et al
    Early mortality after implantable cardioverter defibrillator: Incidence and associated factors.
    Int J Cardiol. 2019 Oct 30. pii: S0167-5273(19)33062.
    >> Share

    June 2019
  458. BACKHAUS SJ, Kowallick JT, Stiermaier T, Lange T, et al
    Atrioventricular mechanical coupling and major adverse cardiac events in female patients following acute ST elevation myocardial infarction.
    Int J Cardiol. 2019 Jun 16. pii: S0167-5273(19)30773.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016